WO2008035728A1 - Sheet for pack - Google Patents

Sheet for pack Download PDF

Info

Publication number
WO2008035728A1
WO2008035728A1 PCT/JP2007/068243 JP2007068243W WO2008035728A1 WO 2008035728 A1 WO2008035728 A1 WO 2008035728A1 JP 2007068243 W JP2007068243 W JP 2007068243W WO 2008035728 A1 WO2008035728 A1 WO 2008035728A1
Authority
WO
WIPO (PCT)
Prior art keywords
molecule
sheet
taxane
cyclic
linear
Prior art date
Application number
PCT/JP2007/068243
Other languages
French (fr)
Japanese (ja)
Inventor
Junko Suda
Changming Zhao
Original Assignee
Advanced Softmaterials Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Softmaterials Inc. filed Critical Advanced Softmaterials Inc.
Publication of WO2008035728A1 publication Critical patent/WO2008035728A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/738Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54Polymers characterized by specific structures/properties

Definitions

  • the present invention relates to a pack sheet having a polytaxane, particularly a pack gel sheet, and more particularly to a pack sheet excellent in flexibility and strength and suitable for supplying moisture to the skin, and particularly to a pack gel sheet. .
  • V a conventional peel-off type packing material having the ability to form a film such as polybutyl alcohol, and the like.
  • S impregnation of sheet-like base material such as nonwoven fabric impregnated with a pack agent Nylon pack materials and gel sheet-type knock materials (see Patent Document 1), in which a gel layer containing a pack agent is provided on the sheet base material, have been developed and are gaining popularity due to their ease of use. .
  • a gel layer containing a pack agent is provided on the sheet base material
  • Patent Document 1 JP-A-58-180408.
  • Patent Document 2 Japanese Patent Laid-Open No. 2005-008613.
  • the impregnated type pack material does not have a sufficient amount of impregnated retention of cosmetic liquid or the like, and the moisture of the cosmetic liquid tends to evaporate during use! Therefore, there is a limit to the supply of moisture to the skin.
  • Gel sheet type products prefer softness with a high moisture content, a cool and cool feeling, but lack hydration to the skin and release of cosmetic ingredients, and have a weak pack effect. There is a problem.
  • these conventional types of sheet packs include an opaque base material such as a nonwoven fabric, there is a problem in that it may seem uncomfortable when applied to the face.
  • Patent Document 2 a gel sheet type packing material composed only of transparent or translucent gel has been developed (see Patent Document 2), but it is used for partial packs such as the eyes and mouth. Limited and full face composed of no support or composed of gel only Large packs for body use are still commercialized.
  • an object of the present invention is to solve the above-described problems.
  • the object of the present invention is to provide a pack sheet, particularly a pack gel sheet, which has excellent moisture supply performance and has strength and flexibility so that it can be made into a large sheet for the entire face without a support. Is to provide.
  • the present inventors have found that the above object can be achieved by using a poly (oral taxane). Specifically, the present inventors have found the following invention.
  • a first poly-oral taxane and ii) a chemical and / or physically bonded pack sheet, particularly a pack gel sheet,
  • first poly (taxane) taxane includes a first cyclic molecule, a first linear molecule that includes the first cyclic molecule in a skewered manner, and the first linear molecule from the first linear molecule. Having a first blocking group disposed at both ends of the first linear molecule so that the cyclic molecule of
  • the b) second poly-taxane is a second cyclic molecule that may be the same as or different from the first cyclic molecule, and a second linear chain that includes the second cyclic molecule in a skewered manner.
  • a second linear molecule which may be the same as or different from the first linear molecule, and the second cyclic molecule is detached from the second linear molecule.
  • a second blocking group disposed at both ends of the second linear molecule so that the second blocking group may be the same as or different from the first blocking group,
  • the first and / or second linear molecular force S polybulal alcohol, polybulurpyrrolidone, poly (meth) acrylic acid, cellulose resin (carboxymethylenosenore Loin, hydroxyethinoresolerose, hydroxypropinoresenorelose, etc.), polyacrylamide, polyethylene oxide, polyethylene glycol, polypropylene glyco Copolymers with polyethylene, polybutylacetal resins, polymethyl ether, polyamine, polyethyleneimine, casein, gelatin, starch, etc. and / or their copolymers, polyethylene, polypropylene, and other olefinic monomers.
  • Polyolefin resins such as polymerized resins, polyester resins, polychlorinated bur resins, polystyrene resins such as polystyrene and talylonitrile-toluene styrene copolymer resins, polymethyl methacrylate and (meth) acrylic acid ester copolymers, acrylonitrile methyl Acrylate resins such as acrylate resins, polycarbonate resins, polyurethane resins, butyl chloride butyl acetate copolymer resins, polybutyl propylal resins, etc .; and derivatives or modified products thereof, polyisobutylene, polytetrahydrofura , Polyaniline, acrylonitrile butadiene styrene copolymer (ABS resin), polyamides such as nylon, polyimides, polygens such as polyisoprene and polybutadiene, polysiloxanes such as polydimethylolsiloxan
  • polyethylene glycol, polyisoprene, polyisobutylene, polybutadiene, polypropylene glycol, polytetrahydrofuran, polydimethylsiloxane, polyethylene, and polypropylene are preferably selected.
  • Polypropylene glycol, poly tetrahydrophthalic run, polydimethylsiloxane, polyethylene, and be selected from the group consisting of polypropylene Yogu is good is in particular polyethylene glycol.
  • the first and / or second linear molecules have a molecular weight of 10,000 or more, preferably 20,000 or more, more preferably 3 . It should be more than 50,000
  • the first and / or second blocking group is a dinitrophenyl group, a cyclodextrin, an adamantane group, a trityl group, or a fluorescein.
  • Pyrenes, substituted benzenes substituted benzenes (substituents include, but are not limited to, alkyl, alkyloxy, hydroxy, halogen, cyano, snorefoninore, force novoxinore, amino, phenol). One or more may be present), may be substituted! / ⁇ may be!
  • polynuclear aromatics (same as the above as substituents) However, it is not limited to these. One or more substituents may be present. ) And steroids. It is preferable to select from the group consisting of dinitrophenyl groups, cyclodextrines, adamantane groups, trityl groups, fluoresceins, and pyrenes, more preferably adamantane groups or trityl groups. It is good.
  • the first and / or second cyclic molecule may be substituted! /, Or may! / ⁇ . Les.
  • the first and / or second cyclic molecule may be a substituted cyclodextrin molecule, and the cyclodextrin molecule is ⁇ - It is selected from the group consisting of cyclodextrin, 13-cyclodextrin, ⁇ -cyclodextrin, and derivatives thereof.
  • the first and / or second cyclic molecule may be substituted ⁇ -cyclodextrin, and the first and / or second The linear molecule is preferably polyethylene glycol.
  • the first cyclic molecule when the first cyclic molecule is skewered by the first linear molecule, the first cyclic molecule is included to the maximum extent.
  • the amount of the first cyclic molecule is 0.001 to 0.6, preferably 0.01 to 0.5, more preferably 0.05 to 0.4. It is preferable that the chain molecules are included in a skewered manner.
  • the second cyclic molecule is the largest when the second cyclic molecule is skewered by the second linear molecule.
  • the second cyclic molecular force is 0.001 to 0.6, preferably (or 0.01 to 0.5, more preferably (or 0.05 to 0.4). It should be included in a skewered manner in the first linear molecule in quantity.
  • a pack sheet particularly a gel sheet for packs, which has excellent moisture supply performance and has strength and flexibility so that it can be made into a large sheet for the entire face without a support.
  • the present invention comprises: i) a first polyortaxane; and ii) the following substances a) and / or b): a) a first polymer other than a polyortaxane;
  • a sheet for a pack comprising i) the first poly (oral taxane) and ii) the substance chemically and / or physically bonded.
  • the pack sheet has a maximum elongation of 200% or higher, a breaking strength of 30 kPa or higher, and an initial elastic modulus of 5 to OOkPa.
  • a first polyoral taxane and ii) a substance, that is, a) a first polymer other than a polyoral taxane; and / or b) a second polyoral taxane; It is preferable that at least a part of is crosslinked.
  • the cross-linking is preferably the following cross-linking (i) to (no). That is, a) Cross-linking of poly-oral taxanes (first poly-orth-taxane and second poly-oral-taxane), cross-linking of polymers other than poly-oral taxanes (ie, “first polymer”) and poly-oral taxanes. , ⁇ ,) Cross-linking in which the above ii) and mouth) are present together.
  • cross-linking may be chemical cross-linking or physical cross-linking, preferably chemical cross-linking, more preferably chemical cross-linking via a cyclic molecule. Is good.
  • the sheet of the present invention itself preferably has the following maximum elongation, breaking strength, and initial elastic modulus.
  • the sheet of the present invention has a maximum elongation of 200% or more, preferably 300% or more, more preferably 400% or more, and a breaking strength of 30 kPa or more, preferably 50 kPa or more, more preferably lOOkPa or more. And an initial elastic modulus of 5 to 100 kPa, preferably 10 to 80 kPa, more preferably (15 to 60 kPa).
  • the sheet of the present invention has sufficient strength and fits to the undulations of the face even though it is thin, even though it has an area that can cover the entire face. Providing a flat or three-dimensional sheet that also has the flexibility to be able to handle.
  • the flexibility that can fit the undulations of the face is defined by the initial modulus and maximum elongation. If the initial elastic modulus exceeds the upper limit, the fitting property tends to deteriorate. Below the lower limit of the maximum elongation, the sheet can be bent and stretched freely. Tendency to affect the fit.
  • sufficient strength is defined by the breaking strength and the initial elastic modulus. If the breaking strength is below the lower limit, the sheet tends to be unable to withstand its own weight and the sheet tends to be broken. Further, when the initial elastic modulus is below the lower limit, the elongation due to its own weight tends to be too large and the shape cannot be maintained. As a result, the sheet tends to be extremely difficult. Therefore, according to the present invention, a sheet having moderate elasticity and flexibility can be provided.
  • the term “sheet” is intended to include a three-dimensional shape, for example, a shape that conforms to the undulations of the face when the entire force is locally flat.
  • a three-dimensional shape along the undulation of the face is included in the “sheet” in the present application because it is locally flat.
  • the whole or flat plate described later in FIG. 2 is also included in the “sheet” in the present application.
  • the sheet having the shape shown in FIG. 1 is formed in a three-dimensional manner, and has a relatively narrow opening at the positions of the eyes, nose and mouth of the human face.
  • the sheet shown in Fig. 1 is useful as a sheet that can cover the entire face, and is effective in that it can uniformly pack the entire face at once and enhances the moisturizing action.
  • the sheet of the present invention includes the first poly-oral taxane, and includes the second poly-oral taxane and / or the first polymer.
  • these constituent substances contained in the sheet of the present invention will be described in detail.
  • Each of the first and / or second poly (taxane) taxanes in the present invention seems to be a cyclic molecule, a linear molecule that includes the cyclic molecule in a skewered manner, and a cyclic molecule that does not desorb from the linear molecule.
  • the second polymouth taxane may be the same as or different from the first polymouth taxane. More specifically, the second cyclic molecule may be the same as or different from the first cyclic molecule, and the second linear molecule may be the same as or different from the first linear molecule.
  • the second blocking group may be the same as or different from the first blocking group. Further, the blocking group disposed at one end of the linear molecule may be the same as or different from the blocking group disposed at the other end.
  • the linear molecule is not particularly limited as long as it is a molecule extending in the longitudinal direction, that is, a linear molecule.
  • a linear molecule polybulal alcohol, polypyrrole pyrrolidone, poly (meth) acrylic acid, cellulose resin (carboxy methinoresenorelose, hydroxyethinoresenorelose, hydroxypropinoresenorelose, etc.), polyacrylamide, Polyethylene oxide, polyethylene glycol, polypropylene glycol, polybulacetal resin, polybulumethyl ether, polyamine, polyethyleneimine, casein, gelatin, starch, etc.
  • Polyolefin resins such as copolymer resins with polyolefin monomers, polyester resins, polychlorinated bur resins, polystyrene resins such as polystyrene and talylonitrile tristyrene copolymer resins
  • Acrylic resins such as polymethyl methacrylate and (meth) acrylic acid ester copolymer, acrylonitrile methyl acrylate copolymer resin, polycarbonate resin, polyurethane resin, butyl chloride acetate copolymer copolymer, polybutyl pentyl resin, etc .; And derivatives or modified products thereof, polyisobutylene, polytetrahydrofuran, polyaniline, acrylonitrile butadiene styrene copolymer (ABS resin), polyamides such as nylon, polygens such as polyimides, polyisoprene, and polybutadiene
  • Polysiloxanes such as polydimethylenosiloxane, polysulfones, polyimines, polyacetic anhydrides, polyureas, polysulfides, polyphosphazenes, polyketones, polyphenylenes, polyhaloolefins And good be selected from the group consisting of induction conductors les, but particularly limited, such les.
  • polyethylene glycol polyisoprene, polyisobutylene, polybutadiene, polypropylene glycol, polytetrahydrofuran, polydimethylsiloxane, polyethylene, and polypropylene, and preferably polyethylene glycol, polypropylene glycol, polytetrahydrofuran, It is particularly preferable to select polyethylene glycol from the group consisting of polydimethylsiloxane, polyethylene, and polypropylene.
  • the linear molecule may have a molecular weight of 10,000 or more, preferably 20,000 or more, more preferably 30,000 or more.
  • the blocking groups are arranged at both ends of the linear molecule as described above.
  • the blocking group has an effect that the cyclic molecule is not detached from the linear molecule.
  • the blocking groups arranged at both ends of the linear molecule may be the same or different at one end and the other end.
  • As blocking groups, dinitrophenyl groups, cyclodextrins, adamantane groups, trityl groups, fluoresceins, pyrenes, substituted benzenes (substituents include alkyl, alkyloxy, hydroxy, halogen, cyan, snorfoninore, carboxyl, amino But not limited thereto, one or more substituents may be present), polynuclear aromatics that may be substituted (substituents are the same as those described above) One or more substituents may be present, but not limited thereto.
  • the dinitrophenyl group is preferably selected from the group consisting of cyclodextrins, adamantane groups, trityl groups, fluoresceins, and pyrenes, more preferably adamantane groups or trityl groups. There should be.
  • the cyclic molecule is not particularly limited as long as it is cyclic and takes the above-described state.
  • the cyclic molecule may be an optionally substituted cyclodextrin molecule.
  • the cyclodextrin molecule may be selected from the group consisting of ⁇ -cyclodextrin, 13-cyclodextrin and ⁇ -cyclodextrin, and derivatives thereof.
  • the cyclic molecule may be an ⁇ -cyclodextrin which may be substituted, and the linear molecule may be polyethylene glycol.
  • the amount of cyclic molecules to be maximally included when the cyclic molecules are skewered by linear molecules is 1, the cyclic molecular force It is preferable to be included in the form of skewers in a linear molecule in an amount of 0.001—0.6, preferably (0,01—0.5, more preferably (0,05—0.4).
  • the sheet of the present invention has ii) a substance in addition to i) the first polyoral taxane.
  • This ii) substance is Either a) below, b) or a mixture of a) and b).
  • a) is the first polymer that is other than a polyoral taxane.
  • b) is a second polytaxane that may be the same as or different from the first polyrotaxane.
  • the first polymer is a polymer other than the polyoral taxane, and is not particularly limited.
  • the first polymer is not particularly limited, but the main chain or side chain is OH group, NH group,
  • photocrosslinking group examples include, but are not limited to, cinnamate, coumarin, chalcone, anthracene, styrylpyridine, styrylpyridinium salt, and styrylquinolium salt.
  • the first polymer may be a homopolymer or a copolymer. It may have two or more polymers. When it has two or more polymers, it is preferable that at least one polymer is bonded to the polyoral taxane via a cyclic molecule. If the first polymer is a copolymer, it may consist of two, three or more monomer forces. When it is a copolymer, the force S can include, but is not limited to, block copolymers, alternating copolymers, random copolymers, graft copolymers, and the like.
  • Examples of the first polymer include polybulal alcohol, polybulurpyrrolidone, poly (meth) acrylic acid, cellulose resins (carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, etc.), polyacrylamide, polyethylene Oxide, Polyethylene glycol, Polypropylene glycol, Polybuacetal resin, Polyvinylmethyl ether, Polyamine, Polyethyleneimine, Casein, Gelatin, Starch, etc.
  • Polyolefin resins such as copolymer resins with polyester monomers, polyester resins, polychlorinated bur resins, polystyrene resins such as polystyrene and acrylonitrile styrene copolymer resins, Acrylic resins such as methyl metatalylate, (meth) acrylic acid ester copolymer, and attarylonitrile trimethyl acrylate copolymer resin, polycarbonate resin, polyurethane resin, butyl chloride, butyl acetate copolymer resin, polybutyral resin, etc.
  • the above-described groups that is, —OH group, —NH group, —COOH group,
  • the material of the present invention may have a second polymouth taxane.
  • the second polymouth taxane may be the same as or different from the first polymouth taxane as described above.
  • the substances constituting the second poly-oral taxane are as described above.
  • the sheet of the present invention may have various components as a pack sheet in addition to the constituent materials described above.
  • humectants such as dipropylene glycol, 1,3-butylene cornore, 1,2-pentanediol, glycerin, propylene glycolanol, collagen, hyanorenoic acid; lecithin, polyglycerin fatty acid ester Emulsifiers such as; oily substances such as squalane, jojoba oil, olive oil; and power S that can include preservatives such as parabens, phenoxyethanol, ethanol, etc., but is not limited thereto.
  • DMF dehydrated dimethylformamide
  • Polypolytaxane prepared in Example 1 (main chain molecular weight 10 million, inclusion rate 26%) to 15 ml of IN NaOH aqueous solution 2. Ig is completely dissolved, and 6 ml of BDGEO. Is added to this solution and mixed. Then, bubbles were removed with ultrasonic waves and poured into a mask mold having a thickness of 0.8 mm and a sample mold for measurement (a strip mold having a thickness of 0.5 mm and a width of 4 mm) and left to stand at 25 ° C. for 24 hours. The obtained gel sheet was taken out from each mold and washed with ion-exchanged water until the alkali was removed from the sheet and became neutral, to obtain a gel sheet for packing A′-1 and a measurement sample A′-2.
  • HEC hydroxyethyl cellulose
  • poly oral taxane solution In 10 ml of IN NaOH aqueous solution, 1.5 g of the poly oral taxane prepared in Example 1 (main chain molecular weight 10 million, inclusion rate 26%) was completely dissolved to obtain a poly oral taxane solution. Separately from this, polybulualcohol (abbreviated as “PVA”, Mw: 31,000 to 50,000, manufactured by Aldrich) 0.7 5 g was dissolved in 5 ml of IN NaOH aqueous solution to obtain a PVA solution. Mix 10 ml of polymouth taxane solution and 5 ml of PVA solution, add 45 ml of BDGEO.
  • PVA polybulualcohol
  • the measurement was performed at 25 ° C and an elongation speed of 0.3 mm / s.
  • the initial elastic modulus was obtained from the slope of the approximate straight line of the Stress-Strain curve up to an elongation of 50% (Fig. 3 shows the initial elastic modulus of the measurement sample A-2 in Example 1. — Indicates an approximate straight line of the strain curve).
  • the maximum extension rate is L for the length of the sample before extension, and the length of the sample at the maximum extension.
  • the gel sheet for packs obtained in Example 1 3 is a sheet that covers the upper half of the face. It has sufficient strength and flexibility, and the sheet does not become brittle due to its own weight. could be used.
  • the pack gel sheet of Comparative Example 2 was difficult to follow the unevenness of the face, which was poorly stretched. On the other hand, it was torn when it was stretched forcibly along the unevenness of the face.
  • the pack gel sheet of Comparative Example 3 was torn during the operation until the shells were held on the face, such as pinching the sheet with fingers and spreading it. From these, it was found that the sheet having the characteristics of the present invention, that is, the maximum elongation, breaking strength, and initial elastic modulus, has the desired performance for the face pack sheet.
  • PVA (Mw: 85,000 to 124,000. Aldrich) 1 ⁇ 5 g was dissolved in 15 ml of DMSO to obtain a PVA solution.
  • 1 ⁇ 5g of the polymouth taxane prepared in Example 1 (main chain molecular weight 100,000, inclusion rate 27%) was completely melted, and BTA 150mg and triethinoleamine 15 ⁇ 1 were calorie-free.
  • bubbles were removed with a centrifuge and poured into a mask mold having a thickness of 0.8 mm and a sample mold for measurement (a strip mold having a thickness of 0.5 mm and a width of 4 mm) and allowed to stand at 25 ° C. for 6 hours.
  • the obtained gel-like sheets are taken out from the respective molds, washed with ion-exchanged water until DMSO is removed from the sheets and the solvent is completely replaced with water, and the gel sheet G-1 for packs and the sampnore G-2 for measurement are used. Got.
  • Example 1 In 10 ml of 2N NaOH aqueous solution, the poly oral taxane prepared in Example 1 (main chain molecular weight 100,000, inclusion rate 27%) 3. Og was completely dissolved to obtain a poly oral taxane solution. Separately, 1.5 g of methylcellulose (hereinafter simply abbreviated as “MC”) (“Metroses (registered trademark) SM-15” manufactured by Shin-Etsu Chemical Co., Ltd.)) is dissolved in 10 ml of water to obtain an MC solution. It was.
  • MC methylcellulose
  • HEC manufactured by Aldrich
  • 15 ml of IN NaOH aqueous solution 3 Og is completely dissolved, BDGE600 1 is added to this solution and mixed, and bubbles are removed by ultrasonic to measure a mask type with a thickness of 0.8 mm.
  • the sample was poured into a sample mold (strip type with a thickness of 0.5 mm and a width of 4 mm) and allowed to stand at 25 ° C for 20 hours.
  • the obtained gel-like sheet was taken out from each mold and washed with ion-exchanged water until the alkali was removed from the sheet and became neutral, to obtain a pack gel sheet M-1 and a measurement sample M-2.
  • the pack gel sheets obtained in Examples 4 to 9 are sheets that cover the upper half of the face, have sufficient strength and flexibility, and do not become brittle due to their own weight. We were able to use without. On the other hand, the pack gel sheet of Comparative Example 4 did not feel stretched even when pulled, and was severed when pulled strongly. Also, when the sheet was bent, the gel was cut or cracked when it was bent.
  • the sheet having the characteristics of the present invention that is, the maximum elongation, breaking strength, and initial elastic modulus has the desired performance for the face pack sheet.
  • FIG. 1 is a view showing an embodiment of the “sheet” of the present application that covers the entire face and has a shape along the face undulation.
  • FIG. 2 is a diagram showing the mask molds used in Examples;! To 9 and Comparative Examples; In the figure, the numbers indicate the unit: mm.
  • FIG. 3 is a stress-strain curve graph for obtaining the initial elastic modulus of Example 1 (A-2).

Abstract

A sheet for packs which has excellent water-supplying performance and has such strength and flexibility that it can be provided as a large sheet for the whole face, etc. without any support. The sheet for packs comprises i) a first polyrotaxane and ii) a substance which is the following a) and/or b): a) a first polymer which is not a polyrotaxane; and b) a second polyrotaxane, the first polyrotaxane i) and the substance ii) being bonded to each other chemically and/or physically. The first and/or second polyrotaxane comprises first and/or second cyclic molecules, a first and/or second linear molecule with which the first and/or second cyclic molecules are pierced and clathrated, and a first and/or second blocking group disposed at each end of the first and/or second linear molecule so as not to release the first and/or second cyclic molecules from the first and/or second linear molecule. The sheet for packs has a maximum elongation of 200% or higher, breaking strength of 30 kPa or higher, and initial modulus of 5-100 kPa.

Description

明 細 書  Specification
パック用シート  Pack sheet
技術分野  Technical field
[0001] 本発明は、ポリ口タキサンを有するパック用シート、特にパック用ゲルシートに関し、 詳しくは柔軟性や強度に優れ、且つ皮膚への水分供給に適したパック用シート、特 にパック用ゲルシートに関する。  TECHNICAL FIELD [0001] The present invention relates to a pack sheet having a polytaxane, particularly a pack gel sheet, and more particularly to a pack sheet excellent in flexibility and strength and suitable for supplying moisture to the skin, and particularly to a pack gel sheet. .
背景技術  Background art
[0002] 従来、ポリビュルアルコール等の皮膜形成能を有する、 V、わゆるピールオフ型のパ ック材が主流であった力 S、不織布などのシート状基材にパック剤を含浸させた含浸タ イブのパック材ゃ、パック剤を含むゲル層をシート基材に設けたゲルシートタイプの ノ ック材(特許文献 1を参照のこと)が開発され、その使いやすさから人気を集めてい る。また、保湿の他にも美白やアンチエイジングなどのスペシャルケア用の製品が多 数市販されている。  [0002] V, a conventional peel-off type packing material having the ability to form a film such as polybutyl alcohol, and the like. S, impregnation of sheet-like base material such as nonwoven fabric impregnated with a pack agent Nylon pack materials and gel sheet-type knock materials (see Patent Document 1), in which a gel layer containing a pack agent is provided on the sheet base material, have been developed and are gaining popularity due to their ease of use. . In addition to moisturizing, many products for special care such as whitening and anti-aging are available on the market.
特許文献 1:特開昭 58— 180408号公報。  Patent Document 1: JP-A-58-180408.
特許文献 2:特開 2005— 008613号公報。  Patent Document 2: Japanese Patent Laid-Open No. 2005-008613.
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0003] しかしながら、含浸タイプのパック材は美容液等の含浸保持量が十分ではなぐま た使用中に美容液の水分が蒸散しやす!/、ため、皮膚への水分供給に限界がある。 一方、ゲルシートタイプの製品は含水量が多ぐ柔ら力、くひんやりと冷涼感のある感 触が好まれているが、皮膚への水分補給や美容成分の放出性に欠け、パック効果が 弱いという問題点がある。また、これら従来のタイプのシートパックは不織布などの不 透明な基材を含んでいるため、顔面に適用したときに見た目の違和感を覚えるといつ た問題もある。 [0003] However, the impregnated type pack material does not have a sufficient amount of impregnated retention of cosmetic liquid or the like, and the moisture of the cosmetic liquid tends to evaporate during use! Therefore, there is a limit to the supply of moisture to the skin. Gel sheet type products, on the other hand, prefer softness with a high moisture content, a cool and cool feeling, but lack hydration to the skin and release of cosmetic ingredients, and have a weak pack effect. There is a problem. In addition, since these conventional types of sheet packs include an opaque base material such as a nonwoven fabric, there is a problem in that it may seem uncomfortable when applied to the face.
この問題に対し、透明または半透明のゲルのみで構成されたゲルシートタイプのパ ック材が開発されたが(特許文献 2を参照のこと)、 目もとや口もとなどの部分用パック 用途に限定されており、支持体なしで構成するか又はゲルのみで構成された顔面全 体用等の大型パックは未だ商品化されてレ、なレ、。 To solve this problem, a gel sheet type packing material composed only of transparent or translucent gel has been developed (see Patent Document 2), but it is used for partial packs such as the eyes and mouth. Limited and full face composed of no support or composed of gel only Large packs for body use are still commercialized.
[0004] そこで、本発明の目的は、上記の課題を解決することにある。 [0004] Therefore, an object of the present invention is to solve the above-described problems.
具体的には、本発明の目的は、水分供給性能に優れ、且つ支持体なしで顔面全 体用などの大きなシートにできるような強度 ·柔軟性を有するパック用シート、特にパ ック用ゲルシートを提供することにある。  Specifically, the object of the present invention is to provide a pack sheet, particularly a pack gel sheet, which has excellent moisture supply performance and has strength and flexibility so that it can be made into a large sheet for the entire face without a support. Is to provide.
課題を解決するための手段  Means for solving the problem
[0005] 本発明者らは、ポリ口タキサンを用いることにより、上記目的を達成できることを見出 した。具体的には、本発明者らは、次の発明を見出した。 [0005] The present inventors have found that the above object can be achieved by using a poly (oral taxane). Specifically, the present inventors have found the following invention.
< 1 > i)第 1のポリ口タキサン;及び ii)以下の a)及び/又は b)の物質;を有し、 a)ポリ口タキサン以外である第 1のポリマー;  <1> i) the first poly-ortaxane; and ii) the following substances a) and / or b): a) the first polymer other than the poly-ortaxane;
b)第 2のポリ口タキサン、  b) a second polymouth taxane,
且つ該 i)第 1のポリ口タキサンと該 ii)物質とが化学的及び/又は物理的に結合して なるパック用シート、特にパック用ゲルシートであって、  And i) a first poly-oral taxane and ii) a chemical and / or physically bonded pack sheet, particularly a pack gel sheet,
前記 i)第 1のポリ口タキサンは、第 1の環状分子、該第 1の環状分子を串刺し状に包 接する第 1の直鎖状分子、及び該第 1の直鎖状分子から前記第 1の環状分子が脱離 しないように第 1の直鎖状分子の両端に配置される第 1の封鎖基を有し、  The i) first poly (taxane) taxane includes a first cyclic molecule, a first linear molecule that includes the first cyclic molecule in a skewered manner, and the first linear molecule from the first linear molecule. Having a first blocking group disposed at both ends of the first linear molecule so that the cyclic molecule of
前記 b)第 2のポリ口タキサンは、第 1の環状分子と同じであっても異なってもよい第 2 の環状分子、該第 2の環状分子を串刺し状に包接する第 2の直鎖状分子であって前 記第 1の直鎖状分子と同じであっても異なってもよい第 2の直鎖状分子、及び該第 2 の直鎖状分子から前記第 2の環状分子が脱離しないように第 2の直鎖状分子の両端 に配置される第 2の封鎖基であって第 1の封鎖基と同じであっても異なってもよい第 2 の封鎖基を有し、  The b) second poly-taxane is a second cyclic molecule that may be the same as or different from the first cyclic molecule, and a second linear chain that includes the second cyclic molecule in a skewered manner. A second linear molecule which may be the same as or different from the first linear molecule, and the second cyclic molecule is detached from the second linear molecule. A second blocking group disposed at both ends of the second linear molecule so that the second blocking group may be the same as or different from the first blocking group,
前記パック用シートの最大伸長率が 200%以上であり、破断強度が 30kPa以上で あり且つ初期弾性率が 5〜; !OOkPaである、上記パック用シート。  The pack sheet as described above, wherein the maximum elongation of the pack sheet is 200% or more, the breaking strength is 30 kPa or more, and the initial elastic modulus is 5 to OOkPa.
[0006] < 2 > 上記 < 1〉において、第 1及び/又は第 2の直鎖状分子力 S、ポリビュルアル コール、ポリビュルピロリドン、ポリ(メタ)アクリル酸、セルロース系樹脂(カルボキシメ チノレセノレロース、ヒドロキシェチノレセノレロース、ヒドロキシプロピノレセノレロース等)、ポリ アクリルアミド、ポリエチレンオキサイド、ポリエチレングリコール、ポリプロピレングリコ ール、ポリビュルァセタール系樹脂、ポリビュルメチルエーテル、ポリアミン、ポリェチ レンィミン、カゼイン、ゼラチン、でんぷん等及び/またはこれらの共重合体、ポリエ チレン、ポリプロピレン、およびその他ォレフィン系単量体との共重合樹脂などのポリ ォレフィン系樹脂、ポリエステル樹脂、ポリ塩化ビュル樹脂、ポリスチレンやアタリロニ トリルースチレン共重合樹脂等のポリスチレン系樹脂、ポリメチルメタタリレートや (メタ) アクリル酸エステル共重合体、アクリロニトリル メチルアタリレート共重合樹脂などの アクリル系樹脂、ポリカーボネート樹脂、ポリウレタン樹脂、塩化ビュル 酢酸ビュル 共重合樹脂、ポリビュルプチラール樹脂等;及びこれらの誘導体又は変性体、ポリイ ソブチレン、ポリテトラヒドロフラン、ポリア二リン、アクリロニトリル ブタジエンースチレ ン共重合体 (ABS樹脂)、ナイロンなどのポリアミド類、ポリイミド類、ポリイソプレン、ポ リブタジエンなどのポリジェン類、ポリジメチノレシロキサンなどのポリシロキサン類、ポリ スルホン類、ポリイミン類、ポリ無水酢酸類、ポリ尿素類、ポリスルフイド類、ポリフォス ファゼン類、ポリケトン類、ポリフエ二レン類、ポリハロォレフイン類、並びにこれらの誘 導体からなる群から選ばれるのがよぐ例えばポリエチレングリコール、ポリイソプレン 、ポリイソブチレン、ポリブタジエン、ポリプロピレングリコール、ポリテトラヒドロフラン、 ポリジメチルシロキサン、ポリエチレン、及びポリプロピレンからなる群から選ばれるの がよぐ好ましくはポリエチレングリコール、ポリプロピレングリコール、ポリテトラヒドロフ ラン、ポリジメチルシロキサン、ポリエチレン、及びポリプロピレンからなる群から選ば れるのがよぐ特にポリエチレングリコールであるのがよい。 <2> In the above item <1>, the first and / or second linear molecular force S, polybulal alcohol, polybulurpyrrolidone, poly (meth) acrylic acid, cellulose resin (carboxymethylenosenore Loin, hydroxyethinoresolerose, hydroxypropinoresenorelose, etc.), polyacrylamide, polyethylene oxide, polyethylene glycol, polypropylene glyco Copolymers with polyethylene, polybutylacetal resins, polymethyl ether, polyamine, polyethyleneimine, casein, gelatin, starch, etc. and / or their copolymers, polyethylene, polypropylene, and other olefinic monomers. Polyolefin resins such as polymerized resins, polyester resins, polychlorinated bur resins, polystyrene resins such as polystyrene and talylonitrile-toluene styrene copolymer resins, polymethyl methacrylate and (meth) acrylic acid ester copolymers, acrylonitrile methyl Acrylate resins such as acrylate resins, polycarbonate resins, polyurethane resins, butyl chloride butyl acetate copolymer resins, polybutyl propylal resins, etc .; and derivatives or modified products thereof, polyisobutylene, polytetrahydrofura , Polyaniline, acrylonitrile butadiene styrene copolymer (ABS resin), polyamides such as nylon, polyimides, polygens such as polyisoprene and polybutadiene, polysiloxanes such as polydimethylolsiloxane, polysulfone , Polyimines, polyacetic anhydrides, polyureas, polysulfides, polyphosphazenes, polyketones, polyphenylenes, polyhaloolefins, and their derivatives. For example, polyethylene glycol, polyisoprene, polyisobutylene, polybutadiene, polypropylene glycol, polytetrahydrofuran, polydimethylsiloxane, polyethylene, and polypropylene are preferably selected. , Polypropylene glycol, poly tetrahydrophthalic run, polydimethylsiloxane, polyethylene, and be selected from the group consisting of polypropylene Yogu is good is in particular polyethylene glycol.
< 3 > 上記く 1〉又はく 2〉にお!/、て、第 1及び/又は第 2の直鎖状分子は、そ の分子量が 1万以上、好ましくは 2万以上、より好ましくは 3. 5万以上であるのがよい  <3> In <1> or <2> above, the first and / or second linear molecules have a molecular weight of 10,000 or more, preferably 20,000 or more, more preferably 3 . It should be more than 50,000
< 4 > 上記< 1〉〜< 3〉のぃずれかにぉぃて、第 1及び/又は第 2の封鎖基が 、ジニトロフエニル基類、シクロデキストリン類、ァダマンタン基類、トリチル基類、フル ォレセイン類、ピレン類、置換ベンゼン類(置換基として、アルキル、アルキルォキシ、 ヒドロキシ、ハロゲン、シァノ、スノレホニノレ、力ノレボキシノレ、ァミノ、フエ二ノレなどを挙げ ることができるがこれらに限定されない。置換基は 1つ又は複数存在してもよい。)、置 換されて!/ヽてもよ!/ヽ多核芳香族類(置換基として、上記と同じものを挙げること力 Sでき るがこれらに限定されない。置換基は 1つ又は複数存在してもよい。)、及びステロイ ド類からなる群から選ばれるのがよい。なお、ジニトロフエニル基類、シクロデキストリ ン類、ァダマンタン基類、トリチル基類、フルォレセイン類、及びピレン類からなる群か ら選ばれるのが好ましぐより好ましくはァダマンタン基類又はトリチル基類であるのが よい。 <4> According to any one of the above <1> to <3>, the first and / or second blocking group is a dinitrophenyl group, a cyclodextrin, an adamantane group, a trityl group, or a fluorescein. , Pyrenes, substituted benzenes (substituents include, but are not limited to, alkyl, alkyloxy, hydroxy, halogen, cyano, snorefoninore, force novoxinore, amino, phenol). One or more may be present), may be substituted! / ヽ may be! / ヽ polynuclear aromatics (same as the above as substituents) However, it is not limited to these. One or more substituents may be present. ) And steroids. It is preferable to select from the group consisting of dinitrophenyl groups, cyclodextrines, adamantane groups, trityl groups, fluoresceins, and pyrenes, more preferably adamantane groups or trityl groups. It is good.
[0008] <5> 上記 <1〉〜<4〉のいずれかにおいて、第 1及び/又は第 2の環状分子 が置換されて!/、てもよ!/ヽシクロデキストリン分子であるのがよレ、。  [0008] <5> In any one of the above items <1> to <4>, the first and / or second cyclic molecule may be substituted! /, Or may! / ヽ. Les.
<6> 上記<1〉〜<5〉のぃずれかにぉぃて、第 1及び/又は第 2の環状分子 が置換されていてもよいシクロデキストリン分子であり、該シクロデキストリン分子が α ーシクロデキストリン、 13ーシクロデキストリン及び γ—シクロデキストリン、並びにその 誘導体からなる群から選ばれるのがよレ、。  <6> In any one of the above items <1> to <5>, the first and / or second cyclic molecule may be a substituted cyclodextrin molecule, and the cyclodextrin molecule is α- It is selected from the group consisting of cyclodextrin, 13-cyclodextrin, γ-cyclodextrin, and derivatives thereof.
[0009] <7> 上記 <1〉〜<6〉のいずれかにおいて、第 1及び/又は第 2の環状分子 が置換されていてもよい α—シクロデキストリンであり、第 1及び/又は第 2の直鎖状 分子がポリエチレングリコールであるのがよい。 <7> In any one of the above items <1> to <6>, the first and / or second cyclic molecule may be substituted α-cyclodextrin, and the first and / or second The linear molecule is preferably polyethylene glycol.
<8> 上記 <1〉〜<7〉のいずれかにおいて、第 1の環状分子が第 1の直鎖状 分子により串刺し状に包接される際に第 1の環状分子が最大限に包接される量を 1と した場合、第 1の環状分子が 0. 001-0. 6、好ましくは 0. 01-0. 5、より好ましくは 0. 05〜0. 4の量で第 1の直鎖状分子に串刺し状に包接されるのがよい。  <8> In any one of the above items <1> to <7>, when the first cyclic molecule is skewered by the first linear molecule, the first cyclic molecule is included to the maximum extent. The amount of the first cyclic molecule is 0.001 to 0.6, preferably 0.01 to 0.5, more preferably 0.05 to 0.4. It is preferable that the chain molecules are included in a skewered manner.
<9> 上記<1〉〜<8〉のぃずれかにぉぃて、第 2の環状分子が第 2の直鎖状 分子により串刺し状に包接される際に第 2の環状分子が最大限に包接される量を 1と した場合、第 2の環状分子力 0. 001-0. 6、好ましく (ま 0. 01-0. 5、より好ましく (ま 0. 05〜0. 4の量で第 1の直鎖状分子に串刺し状に包接されるのがよい。  <9> According to any of <1> to <8> above, the second cyclic molecule is the largest when the second cyclic molecule is skewered by the second linear molecule. When the amount included in the limit is 1, the second cyclic molecular force is 0.001 to 0.6, preferably (or 0.01 to 0.5, more preferably (or 0.05 to 0.4). It should be included in a skewered manner in the first linear molecule in quantity.
発明の効果  The invention's effect
[0010] 本発明により、水分供給性能に優れ、且つ支持体なしで顔面全体用などの大きな シートにできるような強度'柔軟性を有するパック用シート、特にパック用ゲルシートを 提供すること力でさる。  [0010] According to the present invention, it is possible to provide a pack sheet, particularly a gel sheet for packs, which has excellent moisture supply performance and has strength and flexibility so that it can be made into a large sheet for the entire face without a support. .
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0011] 以下、本発明を詳細に説明する。 本発明は、 i)第 1のポリ口タキサン;及び ii)以下の a)及び/又は b)の物質;を有し、 a)ポリ口タキサン以外である第 1のポリマー; Hereinafter, the present invention will be described in detail. The present invention comprises: i) a first polyortaxane; and ii) the following substances a) and / or b): a) a first polymer other than a polyortaxane;
b)第 2のポリ口タキサン、  b) a second polymouth taxane,
且つ該 i)第 1のポリ口タキサンと該 ii)物質とが化学的及び/又は物理的に結合して なるパック用シートを提供する。該パック用シートは、その最大伸長率が 200%以上 であり、破断強度が 30kPa以上であり且つ初期弾性率が 5〜; !OOkPaである。  And a sheet for a pack comprising i) the first poly (oral taxane) and ii) the substance chemically and / or physically bonded. The pack sheet has a maximum elongation of 200% or higher, a breaking strength of 30 kPa or higher, and an initial elastic modulus of 5 to OOkPa.
[0012] 本発明のシートにおいて、 i)第 1のポリ口タキサンと ii)物質、即ち a)ポリ口タキサン以 外である第 1のポリマー;及び/又は b)第 2のポリ口タキサン、とは、その少なくとも一 部が架橋されているのがよい。架橋は、次のィ)〜ノ、)の架橋であるのがよい。即ち、 ィ)ポリ口タキサン同士(第 1のポリ口タキサンと第 2のポリ口タキサン)の架橋、口)ポリ口 タキサン以外のポリマー(即ち「第 1のポリマー」 )とポリ口タキサンとの架橋、ノ、)上記ィ )と口)とが共に存在する架橋。 [0012] In the sheet of the present invention, i) a first polyoral taxane, and ii) a substance, that is, a) a first polymer other than a polyoral taxane; and / or b) a second polyoral taxane; It is preferable that at least a part of is crosslinked. The cross-linking is preferably the following cross-linking (i) to (no). That is, a) Cross-linking of poly-oral taxanes (first poly-orth-taxane and second poly-oral-taxane), cross-linking of polymers other than poly-oral taxanes (ie, “first polymer”) and poly-oral taxanes. , ノ,) Cross-linking in which the above ii) and mouth) are present together.
また、架橋は、化学的な架橋であっても物理的な架橋であってもよぐ好ましくは化 学的な架橋であるのがよぐより好ましくは環状分子を介しての化学的架橋であるの がよい。  Further, the cross-linking may be chemical cross-linking or physical cross-linking, preferably chemical cross-linking, more preferably chemical cross-linking via a cyclic molecule. Is good.
[0013] 本発明のシートは、それ自体が次の最大伸長率、破断強度、及び初期弾性率を有 するのがよい。  [0013] The sheet of the present invention itself preferably has the following maximum elongation, breaking strength, and initial elastic modulus.
即ち、本発明のシートは、その最大伸長率が 200%以上、好ましくは 300%以上、 より好ましくは 400%以上であり、破断強度が 30kPa以上、好ましくは 50kPa以上、よ り好ましくは lOOkPa以上であり且つ初期弾性率が 5〜100kPa、好ましくは 10〜80 kPa、より好ましく (ま 15〜60kPaであるのカょレヽ。  That is, the sheet of the present invention has a maximum elongation of 200% or more, preferably 300% or more, more preferably 400% or more, and a breaking strength of 30 kPa or more, preferably 50 kPa or more, more preferably lOOkPa or more. And an initial elastic modulus of 5 to 100 kPa, preferably 10 to 80 kPa, more preferably (15 to 60 kPa).
これらの特性を有することにより、本発明のシートは、薄くても、顔面全体を覆うこと ができる程度の面積を有するにもかかわらず、十分な強度を有し、且つ顔面の起伏 にフィットすることができる柔軟性をも備える、平板状又は立体状のシートを提供する こと力 Sでさる。  By having these characteristics, the sheet of the present invention has sufficient strength and fits to the undulations of the face even though it is thin, even though it has an area that can cover the entire face. Providing a flat or three-dimensional sheet that also has the flexibility to be able to handle.
特に、顔面の起伏にフィットすることができる柔軟性に関しては、初期弾性率及び 最大伸長率によって規定される。初期弾性率は、その上限を超えるとフィット性が悪く なる傾向が生じる。最大伸長率の下限を下回るとシートの曲げ伸ばしが自由に行え ない傾向が生じ、フィット性に影響する。 In particular, the flexibility that can fit the undulations of the face is defined by the initial modulus and maximum elongation. If the initial elastic modulus exceeds the upper limit, the fitting property tends to deteriorate. Below the lower limit of the maximum elongation, the sheet can be bent and stretched freely. Tendency to affect the fit.
また、十分な強度に関しては、破断強度及び初期弾性率によって規定される。破断 強度は、その下限を下回ると、シートの自重に耐えられない傾向及びそれによりシー トが破れる傾向が生じる。また、初期弾性率は、その下限を下回ると自重による伸び が大きすぎる傾向及びそれにより形状が保てない傾向が生じ、結果としてシートが极 いにくいものになる傾向が生じる。したがって、本発明により、適度な弾力性と柔軟性 を持ったシートを提供することができる。  Moreover, sufficient strength is defined by the breaking strength and the initial elastic modulus. If the breaking strength is below the lower limit, the sheet tends to be unable to withstand its own weight and the sheet tends to be broken. Further, when the initial elastic modulus is below the lower limit, the elongation due to its own weight tends to be too large and the shape cannot be maintained. As a result, the sheet tends to be extremely difficult. Therefore, according to the present invention, a sheet having moderate elasticity and flexibility can be provided.
なお、本願において、「シート」とは、局所的に平板状のものではある力 全体とした 場合には立体状のもの、例えば顔面の起伏に沿う形状を有するものをも含む意であ る。例えば、図 1に示すように、顔面の起伏に沿う立体状のものであっても、局所的に は平板状であるために本願における「シート」に含まれる。また、図 2に後述する、全 体としても平板状のものも、本願における「シート」に含まれる。なお、図 1の形状を有 するシートは、立体的に形成され、人の顔貌の眼と鼻と口の位置に比較的狭い開口 部を形成してなる。図 1のシートは、顔面全体を覆うことができるシートとして有用であ り、顔面全体を一度に、均一的にパックすることができ、保湿作用を高めるなどの点 で有効である。  In the present application, the term “sheet” is intended to include a three-dimensional shape, for example, a shape that conforms to the undulations of the face when the entire force is locally flat. For example, as shown in FIG. 1, even a three-dimensional shape along the undulation of the face is included in the “sheet” in the present application because it is locally flat. In addition, the whole or flat plate described later in FIG. 2 is also included in the “sheet” in the present application. Note that the sheet having the shape shown in FIG. 1 is formed in a three-dimensional manner, and has a relatively narrow opening at the positions of the eyes, nose and mouth of the human face. The sheet shown in Fig. 1 is useful as a sheet that can cover the entire face, and is effective in that it can uniformly pack the entire face at once and enhances the moisturizing action.
[0014] 本発明のシートは、上述のように、第 1のポリ口タキサンを有し、第 2のポリ口タキサン 及び/又は第 1のポリマーを有する。以下、本発明のシートに含まれる、これらの構 成物質について、詳述する。  [0014] As described above, the sheet of the present invention includes the first poly-oral taxane, and includes the second poly-oral taxane and / or the first polymer. Hereinafter, these constituent substances contained in the sheet of the present invention will be described in detail.
[0015] <ポリ口タキサン〉  [0015] <Polymouth taxane>
本発明における第 1及び/又は第 2のポリ口タキサンは各々、環状分子、該環状分 子を串刺し状に包接する直鎖状分子、及び該直鎖状分子から環状分子が脱離しな いように直鎖状分子の両端に配置される封鎖基を有する。  Each of the first and / or second poly (taxane) taxanes in the present invention seems to be a cyclic molecule, a linear molecule that includes the cyclic molecule in a skewered manner, and a cyclic molecule that does not desorb from the linear molecule. Have blocking groups located at both ends of the linear molecule.
第 2のポリ口タキサンは、第 1のポリ口タキサンと同じであっても異なってもよい。より 具体的には、第 2の環状分子は第 1の環状分子と同じであっても異なってもよぐ第 2 の直鎖状分子は第 1の直鎖状分子と同じであっても異なってもよぐ第 2の封鎖基は 第 1の封鎖基と同じであっても異なってもよい。さらに、直鎖状分子の一端に配置さ れる封鎖基は、他端に配置される封鎖基と同じであっても異なってもよい。 [0016] <ポリ口タキサンの直鎖状分子〉 The second polymouth taxane may be the same as or different from the first polymouth taxane. More specifically, the second cyclic molecule may be the same as or different from the first cyclic molecule, and the second linear molecule may be the same as or different from the first linear molecule. The second blocking group may be the same as or different from the first blocking group. Further, the blocking group disposed at one end of the linear molecule may be the same as or different from the blocking group disposed at the other end. [0016] <Linear molecule of poly (oral taxane)>
本発明の材料のポリ口タキサンにおいて、直鎖状分子は、長手方向に伸びる分子、 即ち直鎖状分子であれば、特に限定されない。この直鎖状分子として、ポリビュルァ ルコール、ポリビュルピロリドン、ポリ(メタ)アクリル酸、セルロース系樹脂(カルボキシ メチノレセノレロース、ヒドロキシェチノレセノレロース、ヒドロキシプロピノレセノレロース等)、ポ リアクリルアミド、ポリエチレンオキサイド、ポリエチレングリコール、ポリプロピレングリコ ール、ポリビュルァセタール系樹脂、ポリビュルメチルエーテル、ポリアミン、ポリェチ レンィミン、カゼイン、ゼラチン、でんぷん等及び/またはこれらの共重合体、ポリエ チレン、ポリプロピレン、およびその他ォレフィン系単量体との共重合樹脂などのポリ ォレフィン系樹脂、ポリエステル樹脂、ポリ塩化ビュル樹脂、ポリスチレンやアタリロニ トリルースチレン共重合樹脂等のポリスチレン系樹脂、ポリメチルメタタリレートや (メタ) アクリル酸エステル共重合体、アクリロニトリル メチルアタリレート共重合樹脂などの アクリル系樹脂、ポリカーボネート樹脂、ポリウレタン樹脂、塩化ビュル 酢酸ビュル 共重合樹脂、ポリビュルプチラール樹脂等;及びこれらの誘導体又は変性体、ポリイ ソブチレン、ポリテトラヒドロフラン、ポリア二リン、アクリロニトリル ブタジエンースチレ ン共重合体 (ABS樹脂)、ナイロンなどのポリアミド類、ポリイミド類、ポリイソプレン、ポ リブタジエンなどのポリジェン類、ポリジメチノレシロキサンなどのポリシロキサン類、ポリ スルホン類、ポリイミン類、ポリ無水酢酸類、ポリ尿素類、ポリスルフイド類、ポリフォス ファゼン類、ポリケトン類、ポリフエ二レン類、ポリハロォレフイン類、並びにこれらの誘 導体からなる群から選ばれるのがよレ、が、特に限定されなレ、。  In the polymouth taxane of the material of the present invention, the linear molecule is not particularly limited as long as it is a molecule extending in the longitudinal direction, that is, a linear molecule. As this linear molecule, polybulal alcohol, polypyrrole pyrrolidone, poly (meth) acrylic acid, cellulose resin (carboxy methinoresenorelose, hydroxyethinoresenorelose, hydroxypropinoresenorelose, etc.), polyacrylamide, Polyethylene oxide, polyethylene glycol, polypropylene glycol, polybulacetal resin, polybulumethyl ether, polyamine, polyethyleneimine, casein, gelatin, starch, etc. and / or copolymers thereof, polyethylene, polypropylene, and others Polyolefin resins such as copolymer resins with polyolefin monomers, polyester resins, polychlorinated bur resins, polystyrene resins such as polystyrene and talylonitrile tristyrene copolymer resins Acrylic resins such as polymethyl methacrylate and (meth) acrylic acid ester copolymer, acrylonitrile methyl acrylate copolymer resin, polycarbonate resin, polyurethane resin, butyl chloride acetate copolymer copolymer, polybutyl pentyl resin, etc .; And derivatives or modified products thereof, polyisobutylene, polytetrahydrofuran, polyaniline, acrylonitrile butadiene styrene copolymer (ABS resin), polyamides such as nylon, polygens such as polyimides, polyisoprene, and polybutadiene. Polysiloxanes such as polydimethylenosiloxane, polysulfones, polyimines, polyacetic anhydrides, polyureas, polysulfides, polyphosphazenes, polyketones, polyphenylenes, polyhaloolefins And good be selected from the group consisting of induction conductors les, but particularly limited, such les.
例えばポリエチレングリコール、ポリイソプレン、ポリイソブチレン、ポリブタジエン、ポ リプロピレングリコール、ポリテトラヒドロフラン、ポリジメチルシロキサン、ポリエチレン、 及びポリプロピレンからなる群から選ばれるのがよぐ好ましくはポリエチレングリコー ノレ、ポリプロピレングリコール、ポリテトラヒドロフラン、ポリジメチルシロキサン、ポリエ チレン、及びポリプロピレンからなる群から選ばれるのがよぐ特にポリエチレングリコ 一ノレであるのがよい。  For example, it is more preferably selected from the group consisting of polyethylene glycol, polyisoprene, polyisobutylene, polybutadiene, polypropylene glycol, polytetrahydrofuran, polydimethylsiloxane, polyethylene, and polypropylene, and preferably polyethylene glycol, polypropylene glycol, polytetrahydrofuran, It is particularly preferable to select polyethylene glycol from the group consisting of polydimethylsiloxane, polyethylene, and polypropylene.
[0017] 直鎖状分子は、その分子量が 1万以上、好ましくは 2万以上、より好ましくは 3万以 上であるのがよい。 [0018] <ポリ口タキサンの封鎖基〉 [0017] The linear molecule may have a molecular weight of 10,000 or more, preferably 20,000 or more, more preferably 30,000 or more. <0018 Blocking Group of Poly Mouth Taxane>
本発明の材料のポリ口タキサンにおいて、封鎖基は、上述のように、直鎖状分子の 両端に配置される。また、封鎖基は、直鎖状分子から環状分子が脱離しない作用を 有する。これらの作用を有する封鎖基であれば、特に限定されない。なお、直鎖状分 子の両端に配置される封鎖基は、一端と他端とが同じであっても異なっても良い。 封鎖基として、ジニトロフエニル基類、シクロデキストリン類、ァダマンタン基類、トリ チル基類、フルォレセイン類、ピレン類、置換ベンゼン類(置換基として、アルキル、 アルキルォキシ、ヒドロキシ、ハロゲン、シァノ、スノレホニノレ、カルボキシル、ァミノ、フ ェニルなどを挙げることができるがこれらに限定されない。置換基は 1つ又は複数存 在してもよい。)、置換されていてもよい多核芳香族類 (置換基として、上記と同じもの を挙げることができるがこれらに限定されない。置換基は 1つ又は複数存在してもよい In the polymouth taxane of the material of the present invention, the blocking groups are arranged at both ends of the linear molecule as described above. In addition, the blocking group has an effect that the cyclic molecule is not detached from the linear molecule. There is no particular limitation as long as it is a blocking group having these functions. The blocking groups arranged at both ends of the linear molecule may be the same or different at one end and the other end. As blocking groups, dinitrophenyl groups, cyclodextrins, adamantane groups, trityl groups, fluoresceins, pyrenes, substituted benzenes (substituents include alkyl, alkyloxy, hydroxy, halogen, cyan, snorfoninore, carboxyl, amino But not limited thereto, one or more substituents may be present), polynuclear aromatics that may be substituted (substituents are the same as those described above) One or more substituents may be present, but not limited thereto.
。)、及びステロイド類からなる群から選ばれるのがよい。なお、ジニトロフエ二ル基類 、シクロデキストリン類、ァダマンタン基類、トリチル基類、フルォレセイン類、及びピレ ン類からなる群から選ばれるのが好ましぐより好ましくはァダマンタン基類又はトリチ ル基類であるのがよい。 . ) And steroids. The dinitrophenyl group is preferably selected from the group consisting of cyclodextrins, adamantane groups, trityl groups, fluoresceins, and pyrenes, more preferably adamantane groups or trityl groups. There should be.
[0019] <ポリ口タキサンの環状分子〉  [0019] <Polycyclic taxane cyclic molecule>
環状分子は、環状であり、上述の状態を採るものであれば、特に限定されない。 環状分子は、置換されていてもよいシクロデキストリン分子であるのがよい。該シクロ デキストリン分子は、 α—シクロデキストリン、 13—シクロデキストリン及び γ—シクロデ キストリン、並びにその誘導体からなる群から選ばれるのがよい。  The cyclic molecule is not particularly limited as long as it is cyclic and takes the above-described state. The cyclic molecule may be an optionally substituted cyclodextrin molecule. The cyclodextrin molecule may be selected from the group consisting of α-cyclodextrin, 13-cyclodextrin and γ-cyclodextrin, and derivatives thereof.
[0020] 本発明の材料のポリ口タキサンにおいて、環状分子が置換されていてもよい α—シ クロデキストリンであり、直鎖状分子がポリエチレングリコールであるのがよい。 [0020] In the polymouth taxane of the material of the present invention, the cyclic molecule may be an α-cyclodextrin which may be substituted, and the linear molecule may be polyethylene glycol.
また、本発明の材料のポリ口タキサンにおいて、環状分子が直鎖状分子により串刺 し状に包接される際に環状分子が最大限に包接される量を 1とした場合、環状分子 力 0. 001—0. 6、好ましく (ま 0. 01—0. 5、より好ましく (ま 0. 05—0. 4の量で直鎖状 分子に串刺し状に包接されるのがよい。  In addition, in the polymouth taxane of the material of the present invention, when the amount of cyclic molecules to be maximally included when the cyclic molecules are skewered by linear molecules is 1, the cyclic molecular force It is preferable to be included in the form of skewers in a linear molecule in an amount of 0.001—0.6, preferably (0,01—0.5, more preferably (0,05—0.4).
[0021] < ii)物質〉 [0021] <ii) Substance>
本発明のシートは、 i)第 1のポリ口タキサンの他に、 ii)物質を有する。この ii)物質は 、以下の a)であるか、 b)であるか、又は a)と b)との混在であるかのいずれかである。 a )は、ポリ口タキサン以外である第 1のポリマーである。また、 b)は、第 1のポリロタキサ ンと同じであっても異なってもよい第 2のポリ口タキサンである。 The sheet of the present invention has ii) a substance in addition to i) the first polyoral taxane. This ii) substance is Either a) below, b) or a mixture of a) and b). a) is the first polymer that is other than a polyoral taxane. In addition, b) is a second polytaxane that may be the same as or different from the first polyrotaxane.
[0022] < ii)物質 a)第 1のポリマー〉 [0022] <ii) Substance a) First polymer>
第 1のポリマーは、ポリ口タキサン以外のポリマーであり、特に限定されない。  The first polymer is a polymer other than the polyoral taxane, and is not particularly limited.
第 1のポリマーとして、特に限定されないが、主鎖又は側鎖に OH基、 NH基、  The first polymer is not particularly limited, but the main chain or side chain is OH group, NH group,
2 COOH基、エポキシ基、ビュル基、チオール基、及び光架橋基からなる群から選 ばれる少なくとも 1種を有するのがよい。なお、光架橋基として、ケィ皮酸、クマリン、 カルコン、アントラセン、スチリルピリジン、スチリルピリジニゥム塩、スチリルキノリウム 塩などを挙げることができるがこれらに限定されない。  2 It should have at least one selected from the group consisting of COOH group, epoxy group, bur group, thiol group, and photocrosslinking group. Examples of the photocrosslinking group include, but are not limited to, cinnamate, coumarin, chalcone, anthracene, styrylpyridine, styrylpyridinium salt, and styrylquinolium salt.
[0023] 第 1のポリマーは、ホモポリマーであってもコポリマーであってもよい。 2種以上のポ リマーを有していてもよぐ 2種以上のポリマーを有する場合には、少なくとも 1種のポ リマーがポリ口タキサンと環状分子を介して結合しているのがよい。第 1のポリマーが コポリマーである場合には、 2種、 3種又はそれ以上のモノマー力、ら成ってもよい。コ ポリマーである場合、ブロックコポリマー、交互コポリマー、ランダムコポリマー、グラフ トコポリマーなどを挙げることができる力 S、これらに限定されない。  [0023] The first polymer may be a homopolymer or a copolymer. It may have two or more polymers. When it has two or more polymers, it is preferable that at least one polymer is bonded to the polyoral taxane via a cyclic molecule. If the first polymer is a copolymer, it may consist of two, three or more monomer forces. When it is a copolymer, the force S can include, but is not limited to, block copolymers, alternating copolymers, random copolymers, graft copolymers, and the like.
[0024] 第 1のポリマーの例として、ポリビュルアルコール、ポリビュルピロリドン、ポリ(メタ)ァ クリル酸、セルロース系樹脂(カルボキシメチルセルロース、ヒドロキシェチルセルロー ス、ヒドロキシプロピルセルロース等)、ポリアクリルアミド、ポリエチレンオキサイド、ポリ エチレングリコール、ポリプロピレングリコール、ポリビュルァセタール系樹脂、ポリビ ニルメチルエーテル、ポリアミン、ポリエチレンィミン、カゼイン、ゼラチン、でんぷん等 及び/またはこれらの共重合体、ポリエチレン、ポリプロピレン、およびその他ォレフ イン系単量体との共重合樹脂などのポリオレフイン系樹脂、ポリエステル樹脂、ポリ塩 化ビュル樹脂、ポリスチレンやアクリロニトリル スチレン共重合樹脂等のポリスチレ ン系樹脂、ポリメチルメタタリレートや (メタ)アクリル酸エステル共重合体、アタリロニトリ ルーメチルアタリレート共重合樹脂などのアクリル系樹脂、ポリカーボネート樹脂、ポリ ウレタン樹脂、塩化ビュル 酢酸ビュル共重合樹脂、ポリビュルプチラール樹脂等; 及びこれらの誘導体又は変性体、ポリイソブチレン、ポリテトラヒドロフラン、ポリアユリ ン、アクリロニトリル—ブタジエン—スチレン共重合体 (ABS樹脂)、ナイロンなどのポ リアミド類、ポリイミド類、ポリイソプレン、ポリブタジエンなどのポリジェン類、ポリジメチ ルシロキサンなどのポリシロキサン類、ポリスルホン類、ポリイミン類、ポリ無水酢酸類 、ポリ尿素類、ポリスルフイド類、ポリフォスファゼン類、ポリケトン類、ポリフエ二レン類 、ポリハロォレフイン類、並びにこれらの誘導体を挙げることができる力 S、これらに限定 されない。なお、誘導体として、上述の基、即ち—OH基、—NH基、—COOH基、 [0024] Examples of the first polymer include polybulal alcohol, polybulurpyrrolidone, poly (meth) acrylic acid, cellulose resins (carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, etc.), polyacrylamide, polyethylene Oxide, Polyethylene glycol, Polypropylene glycol, Polybuacetal resin, Polyvinylmethyl ether, Polyamine, Polyethyleneimine, Casein, Gelatin, Starch, etc. and / or copolymers thereof, polyethylene, polypropylene, and other resins Polyolefin resins such as copolymer resins with polyester monomers, polyester resins, polychlorinated bur resins, polystyrene resins such as polystyrene and acrylonitrile styrene copolymer resins, Acrylic resins such as methyl metatalylate, (meth) acrylic acid ester copolymer, and attarylonitrile trimethyl acrylate copolymer resin, polycarbonate resin, polyurethane resin, butyl chloride, butyl acetate copolymer resin, polybutyral resin, etc. And derivatives or modified products thereof, polyisobutylene, polytetrahydrofuran, polyauri , Acrylonitrile-butadiene-styrene copolymer (ABS resin), polyamides such as nylon, polyimides, polyisoprene, polybutadiene such as polybutadiene, polysiloxanes such as polydimethylsiloxane, polysulfones, polyimines, poly Forces S that may include acetic anhydrides, polyureas, polysulfides, polyphosphazenes, polyketones, polyphenylenes, polyhaloolefins, and derivatives thereof are not limited to these. In addition, as the derivative, the above-described groups, that is, —OH group, —NH group, —COOH group,
2  2
エポキシ基、ビュル基、チオール基、及び光架橋基からなる群から選ばれる少なくと も 1種を有するのがよい。  It is preferable to have at least one selected from the group consisting of an epoxy group, a bur group, a thiol group, and a photocrosslinking group.
[0025] < ii)物質 a)第 2のポリ口タキサン〉  [0025] <ii) Substance a) Second poly-oral taxane>
本発明の材料は、第 2のポリ口タキサンを有してもよい。この場合、第 2のポリ口タキ サンは、上述したように、第 1のポリ口タキサンと同じであっても異なってもよい。なお、 第 2のポリ口タキサンを構成する物質は、上述したとおりである。  The material of the present invention may have a second polymouth taxane. In this case, the second polymouth taxane may be the same as or different from the first polymouth taxane as described above. The substances constituting the second poly-oral taxane are as described above.
[0026] 本発明のシートは、上述の構成物質の他に、パック用シートとして、種々の成分を 有してもよい。種々の成分として、例えば、ジプロピレングリコール、 1,3-ブチレンダリ コーノレ、 1,2-ペンタンジォーノレ、グリセリン、プロピレングリコーノレ、コラーゲン、ヒアノレ ロン酸などの保湿剤;レシチン、ポリグリセリン脂肪酸エステルなどの乳化剤;スクワラ ン、ホホバ油、ォリーブ油などの油性物質;及びパラベン類、フエノキシエタノール、 エタノールなどの防腐剤などを挙げることができる力 S、これらに限定されない。  [0026] The sheet of the present invention may have various components as a pack sheet in addition to the constituent materials described above. As various components, for example, humectants such as dipropylene glycol, 1,3-butylene cornore, 1,2-pentanediol, glycerin, propylene glycolanol, collagen, hyanorenoic acid; lecithin, polyglycerin fatty acid ester Emulsifiers such as; oily substances such as squalane, jojoba oil, olive oil; and power S that can include preservatives such as parabens, phenoxyethanol, ethanol, etc., but is not limited thereto.
以下、実施例に基づいて、本発明をさらに詳細に説明するが、本発明は本実施例 に限定されるものではない。  EXAMPLES Hereinafter, although this invention is demonstrated in detail based on an Example, this invention is not limited to a present Example.
実施例 1  Example 1
[0027] <ポリ口タキサン(主鎖分子量 10万)の調製〉  [0027] <Preparation of poly (oral) taxane (main chain molecular weight: 100,000)>
< <ポリエチレングリコールの TEMPO酸化による PEG-カルボン酸の調製〉 > ポリエチレングリコール(PEG) (分子量 10万) 10g、 TEMPO (2,2,6,6-テトラメチル - 1-ピペリジニルォキシラジカル) 50mg、及び臭化ナトリウム 0. 25gを水 110mlに溶 解した。得られた溶液に市販の次亜塩素酸ナトリウム水溶液(有効塩素濃度約 5%) 2. 5mlを添加し、室温で攪拌しながら反応させた。反応が進行すると添加直後から 系の pHは急激に減少する力 なるべく pH : 10〜; 11を保つように IN NaOHを添加 して調製した。 pHの低下は概ね 3分以内に見られなくなつたが、さらに 10分間攪拌 した。過剰量のエタノールを添加して反応を終了させた。塩化メチレン 50mlでの抽 出を 3回繰返して無機塩以外の成分を抽出した後、エバポレータで塩化メチレンを留 去した。温エタノール 250mlに溶解させた後、 4°Cの冷凍庫にー晚おいて PEG— カルボン酸、即ち PEGの両末端をカルボン酸(一 COOH)に置換したもの、を析出さ せた。析出した PEG 力ルボン酸を遠心分離で回収した。この温エタノール溶解 析出 遠心分離のサイクルを数回繰り返し、最後に真空乾燥で乾燥させて PEG— カルボン酸を得た。収率 95%以上。カルボキシル化率 95%以上。 <<Preparation of PEG-carboxylic acid by TEMPO oxidation of polyethylene glycol>> Polyethylene glycol (PEG) (molecular weight 100,000) 10g, TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy radical) 50mg And 0.25 g of sodium bromide was dissolved in 110 ml of water. To the obtained solution, 2.5 ml of a commercially available sodium hypochlorite aqueous solution (effective chlorine concentration: about 5%) was added and reacted at room temperature with stirring. Immediately after the addition of the reaction, the pH of the system suddenly decreases. IN NaOH is added to maintain the pH as high as 10 to 11; Prepared. The drop in pH almost disappeared within 3 minutes, but the mixture was further stirred for 10 minutes. Excess ethanol was added to terminate the reaction. Extraction with 50 ml of methylene chloride was repeated three times to extract components other than inorganic salts, and then the methylene chloride was removed with an evaporator. After dissolving in 250 ml of warm ethanol, it was placed in a freezer at 4 ° C. to precipitate PEG-carboxylic acid, that is, PEG having both ends replaced with carboxylic acid (one COOH). The precipitated PEG strong rubonic acid was recovered by centrifugation. This hot ethanol dissolution precipitation centrifugation cycle was repeated several times, and finally dried by vacuum drying to obtain PEG-carboxylic acid. Yield over 95%. Carboxylation rate is 95% or more.
[0028] < < PEG-カルボン酸と α—シクロデキストリンを用いた包接錯体の調製〉〉 [0028] <<Preparation of inclusion complex using PEG-carboxylic acid and α-cyclodextrin >>
上記で調製した PEG カルボン酸 6g及び α シクロデキストリン(a— CD) 24gを それぞれ別々に用意した 70°Cの温水 100mlに溶解させた後、両者を混合し、その 後、冷蔵庫 (4°C)中で 3日間静置した。クリーム状に析出した包接錯体を凍結乾燥し 回収した。  Dissolve 6 g of PEG carboxylic acid prepared above and 24 g of α-cyclodextrin (a-CD) separately in 100 ml of 70 ° C hot water, mix them, and then mix them in the refrigerator (4 ° C). It was left still for 3 days. The clathrate complex deposited in cream was lyophilized and collected.
[0029] < <ァダマンタンァミンと BOP試薬反応系を用いた包接錯体の封鎖〉 >  [0029] <<Sealing of inclusion complex using adamantanamin and BOP reagent reaction system>
上記包接錯体にァダマンタンアミン 0· 26g、 BOP試薬(ベンゾトリアゾール -1-ィル -ォキシ-トリス(ジメチルァミノ)ホスホニゥム ·へキサフルオロフォスフェート) 0. 60g、 ジイソプロピルェチルァミン 0· 28mlを脱水ジメチルホルムアミド(DMF) 120mlに溶 解した溶液を加え、よく振り混ぜた後、冷蔵庫中でー晚静置した。その後、メタノーノレ 120mlを加え、攪拌、遠心分離、上澄みの除去、を行った。次いで、 DMF/メタノー ル = 1 : 1混合溶液 200mlを加え、同様の操作を 2回行った。さらにメタノール 200ml を用いて同様の操作を 2回行い、得られた沈澱を真空乾燥した後、ジメチルスルホキ シド(DMSO) 140mlに溶解した。この溶液を純水 1400ml中に滴下してポリ口タキ サンを析出させた。析出したポリ口タキサンを遠心分離で回収し、真空乾燥した。さら に同様の再沈澱操作を行い、ポリ口タキサン 16gを得た。得られたポリ口タキサンを N MR測定した結果、 CDと PEGモノマーとの比(モル比)は、 CD : PEGモノマー = 13 . 5 : 100であった(包接率: 27%)  Adamantaneamine 0 · 26g, BOP reagent (benzotriazole-1-yl-oxy-tris (dimethylamino) phosphonium hexafluorophosphate) 0.60g, diisopropylethylamine 0 · 28ml Was added to a solution of 120 ml of dehydrated dimethylformamide (DMF), shaken well, and allowed to stand in a refrigerator. Thereafter, 120 ml of methanol was added, and stirring, centrifugation, and removal of the supernatant were performed. Next, 200 ml of a DMF / methanol = 1: 1 mixed solution was added, and the same operation was performed twice. Further, the same operation was performed twice using 200 ml of methanol, and the resulting precipitate was vacuum-dried and then dissolved in 140 ml of dimethylsulfoxide (DMSO). This solution was dropped into 1400 ml of pure water to precipitate poly-tacky taxane. Precipitated polymouth taxane was collected by centrifugation and dried in vacuum. Further, the same reprecipitation operation was performed to obtain 16 g of a polymouth taxane. As a result of N MR measurement of the obtained poly (oral taxane), the ratio (molar ratio) of CD to PEG monomer was CD: PEG monomer = 13.5: 100 (inclusion rate: 27%)
[0030] <本発明のシートの調製〉  <Preparation of sheet of the present invention>
IN NaOH水溶液 15mlに対し、ポリ口タキサン(主鎖分子量 10万)(包接率 27%) 3. Ogを完全に溶解し、この溶液に 1,4-ブタンジオールジグリシジルエーテル(BDG E) 0. 6mlを加えて混合し、超音波で気泡を除去して厚さ 0. 8mmのマスク型と測定 用サンプル型(厚み 0· 5mm、 幅 4mmの短冊型)に流し入れ、 25°Cで 24時間静置 した。得られたゲル状シートをそれぞれの型から取出し、シートからアルカリが抜けて 中性になるまでイオン交換水で洗浄し、パック用ゲルシート A— 1 (シートの正面図は 図 2参照のこと。以降の実施例及び比較例におレ、ても同様)及び測定用サンプル A 2を得た。 15 ml of IN NaOH aqueous solution, poly oral taxane (main chain molecular weight 100,000) (inclusion rate 27%) 3. Dissolve Og completely, add 0.6 ml of 1,4-butanediol diglycidyl ether (BDG E) to this solution, mix, remove bubbles with ultrasound, and make a mask with a thickness of 0.8 mm And poured into a sample mold for measurement (a strip type with a thickness of 0.5 mm and a width of 4 mm) and left to stand at 25 ° C for 24 hours. The obtained gel-like sheet is taken out from each mold, washed with ion-exchanged water until the alkali is removed from the sheet and becomes neutral, and pack gel sheet A-1 (See Fig. 2 for the front view of the sheet. And the sample A2 for measurement were obtained.
実施例 2  Example 2
[0031] <ポリ口タキサン(主鎖分子量 3. 5万)の調製〉  [0031] <Preparation of poly (oral) taxane (main chain molecular weight 350,000)>
< < PEGの TEMPO酸化による PEG-カルボン酸の調製〉 >  <<Preparation of PEG-carboxylic acid by TEMPO oxidation of PEG>>
PEG (分子量 3· 5万) 10g、 TEMPO (2,2,6,6-テトラメチル -1-ピペリジニルォキシ ラジカル) 100mg、及び臭化ナトリウム lgを水 100mlに溶解した。得られた溶液に巿 販の次亜塩素酸ナトリウム水溶液(有効塩素濃度約 5%) 5mlを添加し、室温で攪拌 しながら反応させた。反応が進行すると添加直後から系の pHは急激に減少するが、 なるべく pH : 10〜; 11を保つように IN NaOHを添加して調製した。 pHの低下は概 ね 3分以内に見られなくなつたが、さらに 10分間攪拌した。エタノールを最大 5mほ での範囲で添加して反応を終了させた。塩化メチレン 50mlでの抽出を 3回繰返して 無機塩以外の成分を抽出した後、エバポレータで塩化メチレンを留去した。温ェタノ ール 250mlに溶解させた後、—4°Cの冷凍庫にー晚おいて PEG 力ルボン酸、即 ち PEGの両末端をカルボン酸(一 COOH)に置換したもの、を析出させた。析出した PEG 力ルボン酸を遠心分離で回収した。この温エタノール溶解 析出 遠心分 離のサイクルを数回繰り返し、最後に真空乾燥で乾燥させて PEG 力ルボン酸を得 た。収率 95%以上。カルボキシル化率 95%以上。  10 g of PEG (molecular weight 350,000), 100 mg of TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy radical), and lg of sodium bromide were dissolved in 100 ml of water. 5 ml of a commercially available sodium hypochlorite aqueous solution (effective chlorine concentration: about 5%) was added to the resulting solution, and the mixture was allowed to react at room temperature with stirring. As the reaction progressed, the pH of the system rapidly decreased immediately after the addition, but was prepared by adding IN NaOH so as to maintain the pH: 10 to 11 as much as possible. The pH drop generally disappeared within 3 minutes, but was stirred for another 10 minutes. Ethanol was added in a range up to about 5 m to terminate the reaction. Extraction with 50 ml of methylene chloride was repeated 3 times to extract components other than inorganic salts, and then methylene chloride was distilled off with an evaporator. After dissolving in 250 ml of hot ethanol, it was placed in a freezer at −4 ° C. to precipitate PEG-powered rubonic acid, that is, one in which both ends of PEG were substituted with carboxylic acid (one COOH). The precipitated PEG strong rubonic acid was recovered by centrifugation. This cycle of hot ethanol dissolution, precipitation, and centrifugal separation was repeated several times, and finally dried by vacuum drying to obtain PEG strong rubonic acid. Yield over 95%. Carboxylation rate is 95% or more.
[0032] < < PEG-カルボン酸と α— CDとを用!/、た包接錯体の調製〉〉  [0032] <<Using PEG-carboxylic acid and α-CD! /, Preparation of inclusion complex >>
上記で調製した PEG カルボン酸 3g及び a—CD9gをそれぞれ別々に用意した 70°Cの温水 50mlに溶解させた後、両者を混合し、その後、冷蔵庫 (4°C)中で一晩 静置した。クリーム状に析出した包接錯体を凍結乾燥し回収した。  3 g of PEG carboxylic acid prepared above and a-CD9 g were dissolved in 50 ml of warm water of 70 ° C separately prepared, then mixed together, and then left overnight in a refrigerator (4 ° C). . The inclusion complex precipitated in the form of cream was lyophilized and recovered.
[0033] < <ァダマンタンァミンと BOP試薬反応系を用いた包接錯体の封鎖〉 > 上記包接錯体にァダマンタンアミン 0· 13g、 BOP試薬(ベンゾトリアゾール -1-ィル -ォキシ-トリス(ジメチルァミノ)ホスホニゥム ·へキサフルオロフォスフェート) 0. 38g、 ジイソプロピルェチルァミン 0· 14mlを脱水ジメチルホルムアミド(DMF) 50mlに溶 解した溶液を加え、よく振り混ぜた後、冷蔵庫中でー晚静置した。その後、メタノーノレ 50mlを加え、攪拌、遠心分離、上澄みの除去、を行った。次いで、 DMF/メタノー ル = 1 : 1混合溶液 100mlを加え、同様の操作を 2回行った。さらにメタノール 100ml を用いて同様の操作を 2回行い、得られた沈澱を真空乾燥した後、ジメチルスルホキ シド(DMSO) 50mlに溶解した。この溶液を純水 700ml中に滴下してポリ口タキサン を析出させた。析出したポリ口タキサンを遠心分離で回収し、真空乾燥した。さらに同 様の再沈澱操作を行い、ポリ口タキサン(主鎖分子量 3. 5万)を 9g得た。得られたポリ 口タキサンを NMR測定した結果、 CDと PEGモノマーとの比(モル比)は、 CD : PEG モノマー = 12· 5 : 100であった(包接率: 25%) [0033] <<Sealing of inclusion complex using adamantanamin and BOP reagent reaction system> Adamantaneamine 0 · 13g, BOP reagent (benzotriazole-1-yl-oxy-tris (dimethylamino) phosphonium hexafluorophosphate) 0.38g, diisopropylethylamine 0 · 14ml A solution dissolved in 50 ml of dehydrated dimethylformamide (DMF) was added, shaken well, and allowed to stand in a refrigerator. Thereafter, 50 ml of methanol was added, followed by stirring, centrifugation, and removal of the supernatant. Subsequently, 100 ml of a DMF / methanol = 1: 1 mixed solution was added, and the same operation was performed twice. Further, the same operation was performed twice using 100 ml of methanol, and the resulting precipitate was vacuum-dried and then dissolved in 50 ml of dimethyl sulfoxide (DMSO). This solution was added dropwise to 700 ml of pure water to precipitate a polymouth taxane. Precipitated polymouth taxane was collected by centrifugation and dried in vacuum. Further, the same reprecipitation operation was carried out to obtain 9 g of a polymouth taxane (main chain molecular weight: 350,000). As a result of NMR measurement of the polypolytaxane obtained, the ratio (molar ratio) of CD to PEG monomer was CD: PEG monomer = 12.5 · 100 (inclusion rate: 25%)
[0034] <本発明のシートの調製〉 <Preparation of sheet of the present invention>
1. 5N NaOH水溶液 15mlに対し、ポリ口タキサン(主鎖分子量 3· 5万) 3. 0gを完 全に溶解し、この溶液に BDGEO. 6mlを加えて混合し、超音波で気泡を除去して厚 さ 0· 8mmのマスク型と測定用サンプル型(厚み 0· 5mm、幅 4mmの短冊型)に流し 入れ、 25°Cで 15時間静置した。得られたゲル状シートをそれぞれの型から取出し、 シートからアルカリが抜けて中性になるまでイオン交換水で洗浄し、パック用ゲルシ ート B— 1及び測定用サンプル B— 2を得た。  1. To 15 ml of 5N NaOH aqueous solution, dissolve 3.0 g of poly (or polytaxane) (main chain molecular weight 350,000), add 6 ml of BDGEO. To this solution, mix, and remove bubbles with ultrasound. Then, it was poured into a mask mold having a thickness of 0.8 mm and a sample mold for measurement (a strip mold having a thickness of 0.5 mm and a width of 4 mm) and allowed to stand at 25 ° C. for 15 hours. The obtained gel-like sheets were taken out from the respective molds and washed with ion-exchanged water until the alkali was removed from the sheets and became neutral, and pack gel sheet B-1 and measurement sample B-2 were obtained.
実施例 3  Example 3
[0035] IN NaOH水溶液 12mlに対し、実施例 1で調製したポリ口タキサン(主鎖分子量 1 0万、包接率 26%) 2. 4gを完全に溶解し、ポリ口タキサン溶液を得た。これとは別に ポリヒドロキシェチルメタタリレート(「p-HEMA」と略記する。分子量 30万、 Aldrich社製 ) 1. 0gを IN NaOH水溶液 5mlに溶解し、 p-HEMA溶液を得た。ポリ口タキサン溶 液 11. 3mlと p-HEMA溶液 3. 8mlを氷浴中で混合し、 BDGE0. 45mlを加えて、遠 心分離機で気泡を除去して厚さ 0. 8mmのマスク型と測定用サンプル型 (厚み 0. 5 mm、幅 4mmの短冊型)に流し入れ、 2°Cで 48時間静置した。得られたゲル状シート をそれぞれの型から取出し、シートからアルカリが抜けて中性になるまでイオン交換 水で洗浄し、パック用ゲルシート C 1及び測定用サンプル C 2を得た。 [0035] 2. 12 g of the poly oral taxane prepared in Example 1 (main chain molecular weight 10 million, inclusion rate 26%) was completely dissolved in 12 ml of IN NaOH aqueous solution to obtain a poly oral taxane solution. Separately, polyhydroxyethyl methacrylate (abbreviated as “p-HEMA”. Molecular weight 300,000, manufactured by Aldrich) 1.0 g was dissolved in 5 ml of IN NaOH aqueous solution to obtain a p-HEMA solution. 11.3 ml of poly-taxane solution and 3.8 ml of p-HEMA solution are mixed in an ice bath, 0.45 ml of BDGE is added, air bubbles are removed with a centrifuge, and a mask type with a thickness of 0.8 mm is obtained. The sample was poured into a measurement sample mold (strip shape with a thickness of 0.5 mm and a width of 4 mm) and allowed to stand at 2 ° C. for 48 hours. The obtained gel-like sheet is taken out from each mold and ion exchange is performed until the alkali is removed from the sheet and becomes neutral. The gel sheet C1 for packs and the sample C2 for measurement were obtained by washing with water.
[0036] (比較例 1) [0036] (Comparative Example 1)
IN NaOH水溶液 15mlに対し、実施例 1で調製したポリ口タキサン(主鎖分子量 1 0万、包接率 26%) 2. lgを完全に溶解し、この溶液に BDGEO. 6mlを加えて混合し 、超音波で気泡を除去して厚さ 0. 8mmのマスク型と測定用サンプル型(厚み 0. 5m m、幅 4mmの短冊型)に流し入れ、 25°Cで 24時間静置した。得られたゲル状シート をそれぞれの型から取出し、シートからアルカリが抜けて中性になるまでイオン交換 水で洗浄し、パック用ゲルシート A'— 1及び測定用サンプル A'— 2を得た。  Polypolytaxane prepared in Example 1 (main chain molecular weight 10 million, inclusion rate 26%) to 15 ml of IN NaOH aqueous solution 2. Ig is completely dissolved, and 6 ml of BDGEO. Is added to this solution and mixed. Then, bubbles were removed with ultrasonic waves and poured into a mask mold having a thickness of 0.8 mm and a sample mold for measurement (a strip mold having a thickness of 0.5 mm and a width of 4 mm) and left to stand at 25 ° C. for 24 hours. The obtained gel sheet was taken out from each mold and washed with ion-exchanged water until the alkali was removed from the sheet and became neutral, to obtain a gel sheet for packing A′-1 and a measurement sample A′-2.
[0037] (比較例 2) [0037] (Comparative Example 2)
IN NaOH水溶液 10mlに対し、実施例 1で調製したポリ口タキサン(主鎖分子量 1 0万、包接率 26%) 1. 5gを完全に溶解し、ポリ口タキサン溶液を得た。これとは別に ヒドロキシェチルセルロース(「HEC」と略記する。 Aldrich社製) 0· 75gを IN NaOH 水溶液 5mlに溶解し、 HEC溶液を得た。ポリ口タキサン溶液 10mlと HEC溶液 5mlを 混合し、 BDGEO. 45mlを加えて、遠心分離機で気泡を除去して厚さ 0. 8mmのマ スク型と測定用サンプル型(厚み 0· 5mm、幅 4mmの短冊型)に流し入れ、 25°Cで 2 4時間静置した。得られたゲル状シートをそれぞれの型から取出し、シートからアル力 リが抜けて中性になるまでイオン交換水で洗浄し、パック用ゲルシート D— 1及び測 定用サンプル D— 2を得た。  In 10 ml of IN NaOH aqueous solution, 1.5 g of the poly oral taxane prepared in Example 1 (main chain molecular weight 10 million, inclusion rate 26%) was completely dissolved to obtain a poly oral taxane solution. Separately, hydroxyethyl cellulose (abbreviated as “HEC”; Aldrich) 0 · 75 g was dissolved in 5 ml of IN NaOH aqueous solution to obtain an HEC solution. Mix 10 ml of polymouth taxane solution and 5 ml of HEC solution, add 45 ml of BDGEO., Remove air bubbles with a centrifuge, and then remove the air bubble with a 0.8 mm thick mask mold and a measurement sample mold (thickness 0.5 mm, width). 4mm strip type) and left at 25 ° C for 24 hours. The obtained gel-like sheets were taken out from the respective molds and washed with ion-exchanged water until the neutral force was removed from the sheets until they became neutral, and pack gel sheet D-1 and measurement sample D-2 were obtained. .
[0038] (比較例 3) [0038] (Comparative Example 3)
IN NaOH水溶液 10mlに対し、実施例 1で調製したポリ口タキサン(主鎖分子量 1 0万、包接率 26%) 1. 5gを完全に溶解し、ポリ口タキサン溶液を得た。これとは別に ポリビュルアルコール (「PVA」と略記する。 Mw: 31,000〜50,000· Aldrich社製) 0. 7 5gを IN NaOH水溶液 5mlに溶解し、 PVA溶液を得た。ポリ口タキサン溶液 10mlと PVA溶液 5mlを混合し、 BDGEO. 45mlを加えて、遠心分離機で気泡を除去して厚 さ 0· 8mmのマスク型と測定用サンプル型(厚み 0· 5mm、幅 4mmの短冊型)に流し 入れ、 25°Cで 24時間静置した。得られたゲル状シートをそれぞれの型から取出し、シ ートからアルカリが抜けて中性になるまでイオン交換水で洗浄し、パック用ゲルシート E 1及び測定用サンプノレ E— 2を得た。 [0039] 実施例:!〜 3及び比較例 1 3で調製した測定用サンプルの初期弾性率、最大伸 長率、破断強度をレオメトリック 'サイエンティフィック'エフ'ィ一社の RSA-IIIで測定し た。 25°C、伸長スピード 0. 3mm/sで測定を行った。なお、初期弾性率は、伸長率 50%までの Stress— Strain曲線の近似直線の傾きから求めた(図 3は、実施例 1の測 定用サンプル A— 2の、初期弾性率を求める、 Stress— Strain曲線の近似直線を示す )。また、最大伸長率は、伸長前のサンプルの長さを L,最大伸長時のサンプルの長 In 10 ml of IN NaOH aqueous solution, 1.5 g of the poly oral taxane prepared in Example 1 (main chain molecular weight 10 million, inclusion rate 26%) was completely dissolved to obtain a poly oral taxane solution. Separately from this, polybulualcohol (abbreviated as “PVA”, Mw: 31,000 to 50,000, manufactured by Aldrich) 0.7 5 g was dissolved in 5 ml of IN NaOH aqueous solution to obtain a PVA solution. Mix 10 ml of polymouth taxane solution and 5 ml of PVA solution, add 45 ml of BDGEO. Remove the bubbles with a centrifuge and remove 0-8 mm thick mask mold and measurement sample mold (thickness 0.5 mm, width 4 mm) And was allowed to stand at 25 ° C for 24 hours. The obtained gel-like sheet was taken out from each mold and washed with ion-exchanged water until the alkali was removed from the sheet and became neutral, to obtain a gel sheet E1 for packs and a sampnore E-2 for measurement. [0039] Examples:! To 3 and Comparative Example 1 The initial elastic modulus, the maximum elongation, and the breaking strength of the measurement samples prepared in 3 were measured with RSA-III of Rheometric 'Scientific' F 'company. It was measured. The measurement was performed at 25 ° C and an elongation speed of 0.3 mm / s. The initial elastic modulus was obtained from the slope of the approximate straight line of the Stress-Strain curve up to an elongation of 50% (Fig. 3 shows the initial elastic modulus of the measurement sample A-2 in Example 1. — Indicates an approximate straight line of the strain curve). The maximum extension rate is L for the length of the sample before extension, and the length of the sample at the maximum extension.
0  0
さを L としたとき、次式により求められる。それらの結果を表 1に示す。  When L is L, the following equation is obtained. The results are shown in Table 1.
max  max
[0040] 圖  [0040] 圖
最大伸長率 = "Q x l00 ( % ) Maximum elongation = " Q x l00 (%)
[0041] [表 1] 表 1 [0041] [Table 1] Table 1
Figure imgf000016_0001
Figure imgf000016_0001
[0042] 実施例 1 3で得られたパック用ゲルシートは、顔面の上部半分を覆うシートである 力 十分な強度及び柔軟性を有しており、自重によりシートがもろくなることもなぐ問 題なく用いることができた。 [0042] The gel sheet for packs obtained in Example 1 3 is a sheet that covers the upper half of the face. It has sufficient strength and flexibility, and the sheet does not become brittle due to its own weight. Could be used.
一方、比較例 1のパック用ゲルシートは、型からゲルを外す際に壊れたり、指でつま み上げたときに自重に耐えられずに破れたりした。  On the other hand, the pack gel sheet of Comparative Example 1 was broken when the gel was removed from the mold, or when it was picked up with a finger, it could not withstand its own weight and was torn.
また、比較例 2のパック用ゲルシートは、伸びが悪ぐ顔の凹凸に沿わせにくかった 。その一方で、顔の凹凸に沿わせようと無理に伸ばすと破れてしまった。  Further, the pack gel sheet of Comparative Example 2 was difficult to follow the unevenness of the face, which was poorly stretched. On the other hand, it was torn when it was stretched forcibly along the unevenness of the face.
さらに、比較例 3のパック用ゲルシートは、シートを指でつまんで広げるなどの、顔に 貝占り付けるまでの操作の間に破れてしまった。 これらのことから、本発明の特性、即ち最大伸長率、破断強度及び初期弾性率を 有するシートは、顔面パック用シートに所望の性能を有することがわかった。 Further, the pack gel sheet of Comparative Example 3 was torn during the operation until the shells were held on the face, such as pinching the sheet with fingers and spreading it. From these, it was found that the sheet having the characteristics of the present invention, that is, the maximum elongation, breaking strength, and initial elastic modulus, has the desired performance for the face pack sheet.
実施例 4  Example 4
[0043] DMSO 15mlに、 PVA(Mw: 85,000〜 124,000· Aldrich社製) 1. 5gを溶解し、 PV A溶液を得た。この PVA溶液に実施例 2で調製したポリ口タキサン(主鎖分子量 3. 5 万、包接率 25%) 1. 5gを完全に溶解し、 1,2,3,4-ブタンテトラカルボン酸二無水和 物(以下、「BTA」と略記する。)300mgとトリエチルァミン 15 1を加えて、遠心分離 機で気泡を除去して厚さ 0. 8mmのマスク型と測定用サンプル型(厚み 0. 5mm、幅 4mmの短冊型)に流し入れ、 25°Cで 7時間静置した。得られたゲル状シートをそれ ぞれの型から取出し、シートから DMSOが抜けて溶媒が完全に水に交換されるまで イオン交換水で洗浄し、ノ ック用ゲルシート F— 1及び測定用サンプル F— 2を得た。 実施例 5  [0043] In 15 ml of DMSO, 1.5 g of PVA (Mw: 85,000 to 124,000 · Aldrich) was dissolved to obtain a PVA solution. In this PVA solution, 1.5 g of the polymouth taxane prepared in Example 2 (main chain molecular weight: 35,000, inclusion rate: 25%) was completely dissolved, and 1,2,3,4-butanetetracarboxylic acid dihydrate was dissolved. Add 300 mg of non-hydrate (hereinafter abbreviated as “BTA”) and triethylamine 15 1, remove air bubbles with a centrifuge, and remove 0.8 mm thick mask mold and measurement sample mold (thickness 0). 5 mm and 4 mm wide strips) and left at 25 ° C for 7 hours. The obtained gel-like sheet is taken out from each mold, washed with ion-exchanged water until DMSO is removed from the sheet and the solvent is completely exchanged with water, and the gel sheet F-1 for measurement and the sample for measurement are used. F-2 was obtained. Example 5
[0044] DMSO 15mlに、 PVA(Mw: 85,000〜 124,000. Aldrich社製) 1 · 5gを溶解し、 PV A溶液を得た。この PVA溶液に実施例 1で調製したポリ口タキサン(主鎖分子量 10万 、包接率 27%) 1 · 5gを完全に溶角早し、 BTA150mgとトリエチノレアミン 15〃1をカロ免 て、遠心分離機で気泡を除去して厚さ 0. 8mmのマスク型と測定用サンプル型 (厚み 0. 5mm、幅 4mmの短冊型)に流し入れ、 25°Cで 6時間静置した。得られたゲル状 シートをそれぞれの型から取出し、シートから DMSOが抜けて溶媒が完全に水に交 換されるまでイオン交換水で洗浄し、パック用ゲルシート G— 1及び測定用サンプノレ G— 2を得た。  [0044] PVA (Mw: 85,000 to 124,000. Aldrich) 1 · 5 g was dissolved in 15 ml of DMSO to obtain a PVA solution. In this PVA solution, 1 · 5g of the polymouth taxane prepared in Example 1 (main chain molecular weight 100,000, inclusion rate 27%) was completely melted, and BTA 150mg and triethinoleamine 15〃1 were calorie-free. Then, bubbles were removed with a centrifuge and poured into a mask mold having a thickness of 0.8 mm and a sample mold for measurement (a strip mold having a thickness of 0.5 mm and a width of 4 mm) and allowed to stand at 25 ° C. for 6 hours. The obtained gel-like sheets are taken out from the respective molds, washed with ion-exchanged water until DMSO is removed from the sheets and the solvent is completely replaced with water, and the gel sheet G-1 for packs and the sampnore G-2 for measurement are used. Got.
実施例 6  Example 6
[0045] 2N NaOH水溶液 10mlに、実施例 1で調製したポリ口タキサン(主鎖分子量 10万 、包接率 27%) 3. Ogを完全に溶解し、ポリ口タキサン溶液を得た。これとは別にメチ ルセルロース(以下、単に「MC」と略記する)(信越化学工業社製「メトローズ (登録商 標) SM-15」)1. 5gを水 10mlに溶解し、 MC溶液を得た。ポリ口タキサン溶液 10. 4g と MC溶液 8. 6gとを混合し、 BDGE600 1を加えて、遠心分離機で気泡を除去して 厚さ 0· 8mmのマスク型と測定用サンプル型(厚み 0· 5mm、幅 4mmの短冊型)に流 し入れ、 25°Cで 19時間静置した。得られたゲル状シートをそれぞれの型から取出し 、シートからアルカリが抜けて中性になるまでイオン交換水で洗浄し、パック用ゲルシ ート H— 1及び測定用サンプノレ H— 2を得た。 [0045] In 10 ml of 2N NaOH aqueous solution, the poly oral taxane prepared in Example 1 (main chain molecular weight 100,000, inclusion rate 27%) 3. Og was completely dissolved to obtain a poly oral taxane solution. Separately, 1.5 g of methylcellulose (hereinafter simply abbreviated as “MC”) (“Metroses (registered trademark) SM-15” manufactured by Shin-Etsu Chemical Co., Ltd.)) is dissolved in 10 ml of water to obtain an MC solution. It was. Mix 10.4 g of poly-taxane taxane solution and 8.6 g of MC solution, add BDGE600 1 and remove bubbles with a centrifuge to remove the 0 · 8 mm thickness mask sample and the measurement sample die (thickness 0 · 5 mm and 4 mm wide strips) and left at 25 ° C for 19 hours. Take out the obtained gel sheet from each mold Then, the sheet was washed with ion-exchanged water until alkali was removed from the sheet and became neutral, to obtain a gel sheet H-1 for pack and a sampnore H-2 for measurement.
実施例 7  Example 7
[0046] <ポリ口タキサン(主鎖分子量 50万)の調製〉  [0046] <Preparation of poly (oral) taxane (main chain molecular weight: 500,000)>
PEGの分子量を 50万とし、且つ包接率を 19%とした以外、実施例 1と同様にして ポリ口タキサン(主鎖分子量 50万、包接率 19%)を得た。  Except that the molecular weight of PEG was 500,000 and the inclusion rate was 19%, a polyortaxane (main chain molecular weight 500,000, inclusion rate 19%) was obtained in the same manner as in Example 1.
[0047] <本発明のシートの調製〉  <Preparation of sheet of the present invention>
IN NaOH水溶液 15mlに、ポリ口タキサン(主鎖分子量 50万、包接率 19%) 1. 5 gを完全に溶解し、この溶液に BDGESOO ^ lを加えて混合し、超音波で気泡を除去 して厚さ 0. 8mmのマスク型と測定用サンプル型(厚み 0· 5mm、 幅 4mmの短冊型) に流し入れ、 25°Cで 24時間静置した。得られたゲル状シートをそれぞれの型から取 出し、シートからアルカリが抜けて中性になるまでイオン交換水で洗浄し、パック用ゲ ルシート I 1及び測定用サンプル I 2を得た。  In 15 ml of IN NaOH aqueous solution, 1.5 g polypolytaxane (main chain molecular weight: 500,000, inclusion rate: 19%) is completely dissolved. Add BDGESOO ^ l to this solution, mix, and remove bubbles with ultrasound. Then, it was poured into a mask mold with a thickness of 0.8 mm and a sample mold for measurement (a strip with a thickness of 0.5 mm and a width of 4 mm) and left at 25 ° C. for 24 hours. The obtained gel-like sheet was taken out from each mold and washed with ion-exchanged water until the alkali was removed from the sheet and became neutral, thereby obtaining a pack gel sheet I1 and a measurement sample I2.
実施例 8  Example 8
[0048] IN NaOH水溶液 15mlに、実施例 7と同様にして調製したポリ口タキサン(主鎖分 子量 50万、包接率 19%) 2. 25gを完全に溶解し、この溶液に BDGE450 1を加え て混合し、超音波で気泡を除去して厚さ 0. 8mmのマスク型と測定用サンプル型 (厚 み 0. 5mm、 幅 4mmの短冊型)に流し入れ、 25°Cで 24時間静置した。得られたゲ ル状シートをそれぞれの型から取出し、シートからアルカリが抜けて中性になるまでィ オン交換水で洗浄し、パック用ゲルシート I 3及び測定用サンプル I 4を得た。 実施例 9  [0048] In 25 ml of IN NaOH aqueous solution, 25 g of polymouth taxane prepared in the same manner as in Example 7 (main chain molecular weight 500,000, inclusion rate 19%) 2. 25 g was completely dissolved, and BDGE450 1 Add and mix, remove bubbles with ultrasonic waves, pour into a mask mold with a thickness of 0.8 mm and a sample mold for measurement (a strip with a thickness of 0.5 mm and a width of 4 mm), and let stand at 25 ° C for 24 hours. I put it. The obtained gel sheets were taken out from the respective molds and washed with ion exchanged water until the alkali was removed from the sheets and became neutral, to obtain pack gel sheet I 3 and measurement sample I 4. Example 9
[0049] DMS〇15mlに、実施例 7と同様にして調製したポリ口タキサン(主鎖分子量 50万、 包接率 19%) 2. 25gを完全に溶解し、この溶液に 1,6-へキサメチレンジイソシァネー ト 150 1を加えて混合し、超音波で気泡を除去して厚さ 0. 8mmのマスク型と測定用 サンプル型(厚み 0· 5mm、 幅 4mmの短冊型)に流し入れ、 60°Cで 15時間静置し た。得られたゲル状シートをそれぞれの型から取出し、シートから DMSOが抜けて溶 媒が完全に水に交換されるまでイオン交換水で洗浄し、ノ ンク用ゲルシート J 1及び 測定用サンプル J 2を得た。 [0050] (比較例 4) [0049] In 15 ml of DMS, a polymouth taxane prepared in the same manner as in Example 7 (main chain molecular weight 500,000, inclusion rate 19%) 2. 25 g was completely dissolved. Add and mix xamethylene diisocyanate 150 1 and remove bubbles with ultrasonic waves, then pour into a mask mold with a thickness of 0.8 mm and a sample mold for measurement (a strip with a thickness of 0.5 mm and a width of 4 mm). And left at 60 ° C for 15 hours. The obtained gel-like sheets are taken out from the respective molds, washed with ion-exchanged water until DMSO is removed from the sheets and the solvent is completely exchanged with water, and the gel sheet J1 for measurement and the measurement sample J2 are removed. Obtained. [0050] (Comparative Example 4)
IN NaOH水溶液 15mlに、 HEC (Aldrich社製) 3. Ogを完全に溶解し、この溶液 に BDGE600 1を加えて混合し、超音波で気泡を除去して厚さ 0. 8mmのマスク型 と測定用サンプル型(厚み 0· 5mm、 幅 4mmの短冊型)に流し入れ、 25°Cで 20時 間静置した。得られたゲル状シートをそれぞれの型から取出し、シートからアルカリが 抜けて中性になるまでイオン交換水で洗浄し、パック用ゲルシート M— 1及び測定用 サンプル M— 2を得た。  HEC (manufactured by Aldrich) in 15 ml of IN NaOH aqueous solution 3. Og is completely dissolved, BDGE600 1 is added to this solution and mixed, and bubbles are removed by ultrasonic to measure a mask type with a thickness of 0.8 mm. The sample was poured into a sample mold (strip type with a thickness of 0.5 mm and a width of 4 mm) and allowed to stand at 25 ° C for 20 hours. The obtained gel-like sheet was taken out from each mold and washed with ion-exchanged water until the alkali was removed from the sheet and became neutral, to obtain a pack gel sheet M-1 and a measurement sample M-2.
[0051] (比較例 5) [0051] (Comparative Example 5)
IN NaOH水溶液 15mlに、 PVA(Mw: 31,000〜50,000· Aldrich社製) 3· Ogを完 全に溶解し、この溶液に BDGEeOO ^ lを加えて混合し、超音波で気泡を除去して厚 さ 0· 8mmのマスク型と測定用サンプル型(厚み 0· 5mm、 幅 4mmの短冊型)に流 し入れ、 25°Cで 15時間静置した。得られたゲル状シートをそれぞれの型から取出し 、シートからアルカリが抜けて中性になるまでイオン交換水で洗浄し、パック用ゲルシ ート N— 1及び測定用サンプル N— 2を得た。測定用サンプル N— 2につ!/、て初期弹 性率、最大伸長率及び破断強度を測定した結果、初期弾性率: lkPa、最大伸長率: 151 %、破断強度: 3kPaであることがわかった。  Dissolve PVA (Mw: 31,000-50,000 Aldrich) 3 · Og completely in 15 ml IN NaOH aqueous solution, add BDGEeOO ^ l to this solution, mix, and remove bubbles with ultrasound Then, it was poured into a mask mold having a thickness of 0.8 mm and a sample mold for measurement (a strip mold having a thickness of 0.5 mm and a width of 4 mm) and allowed to stand at 25 ° C. for 15 hours. The obtained gel-like sheet was taken out from each mold and washed with ion-exchanged water until the alkali was removed from the sheet and became neutral to obtain a pack gel sheet N-1 and a measurement sample N-2. Measurement sample N-2 was measured for initial strength, maximum elongation, and breaking strength. As a result, it was found that initial elastic modulus: lkPa, maximum elongation: 151%, and breaking strength: 3kPa. It was.
[0052] (比較例 6) [0052] (Comparative Example 6)
IN NaOH水溶液 15mlに、 PVA(Mw: 85,000〜 124,000· Aldrich社製) 2· 25gを 完全に溶解し、この溶液に BDGE450 1を加えて混合し、超音波で気泡を除去して 厚さ 0. 8mmのマスク型と測定用サンプル型(厚み 0. 5mm、 幅 4mmの短冊型)に 流し入れ、 25°Cで 15時間静置した。得られたゲル状シートをそれぞれの型から取出 し、シートからアルカリが抜けて中性になるまでイオン交換水で洗浄し、パック用ゲル シート P— 1及び測定用サンプル P— 2を得た。測定用サンプル P— 2につレ、て初期 弾性率、最大伸長率及び破断強度を測定した結果、初期弾性率: 3kPa、最大伸長 率: 170%、破断強度: 7kPaであることがわかった。  IN NaOH aqueous solution 15ml, PVA (Mw: 85,000-124,000 · Aldrich) 2 · 25g is completely dissolved, BDGE450 1 is added to this solution and mixed, and bubbles are removed by ultrasonic to remove the thickness. It was poured into a mask mold of 0.8 mm and a sample mold for measurement (a strip of 0.5 mm thickness and 4 mm width) and allowed to stand at 25 ° C. for 15 hours. The obtained gel-like sheet was taken out from each mold and washed with ion-exchanged water until the alkali was removed from the sheet and became neutral, to obtain a pack gel sheet P-1 and a measurement sample P-2. As a result of measuring the initial elastic modulus, the maximum elongation rate, and the breaking strength of the measurement sample P-2, it was found that the initial elastic modulus: 3 kPa, the maximum elongation rate: 170%, and the breaking strength: 7 kPa.
[0053] 実施例 4〜9で得られたパック用ゲルシートは、顔面の上部半分を覆うシートである 、十分な強度及び柔軟性を有しており、自重によりシートがもろくなることもなぐ問 題なく用いることができた。 一方、比較例 4のパック用ゲルシートは、引っ張っても伸びる感じがせず、強く引つ 張るとポッンと切れてしまった。また、シートを折り曲げると、曲げたところでゲルが切 れるか又は割れてしまった。 [0053] The pack gel sheets obtained in Examples 4 to 9 are sheets that cover the upper half of the face, have sufficient strength and flexibility, and do not become brittle due to their own weight. We were able to use without. On the other hand, the pack gel sheet of Comparative Example 4 did not feel stretched even when pulled, and was severed when pulled strongly. Also, when the sheet was bent, the gel was cut or cracked when it was bent.
比較例 5及び 6のパック用ゲルシートは、ゲル同士がくっつきやすく且つ非常に柔ら かぐ広げて肌にのせるなどの作業が非常に困難であった。また、指でつまみ上げる と自重に耐えきれずやぶれてしまった。  In the gel sheets for packing of Comparative Examples 5 and 6, the gels were easy to stick to each other, and it was very difficult to perform such operations as spreading them softly and putting them on the skin. Also, when I picked it up with my finger, I couldn't stand its own weight and got struck.
これらのことから、本発明の特性、即ち最大伸長率、破断強度及び初期弾性率を 有するシートは、顔面パック用シートに所望の性能を有することがわ力、つた。  From these facts, it was found that the sheet having the characteristics of the present invention, that is, the maximum elongation, breaking strength, and initial elastic modulus has the desired performance for the face pack sheet.
[表 2] [Table 2]
表 2. 実施例 4~9及び比較例 4~6のサンプルの測定結果 Table 2. Measurement results of samples of Examples 4 to 9 and Comparative Examples 4 to 6
Figure imgf000021_0001
Figure imgf000021_0001
図面の簡単な説明 Brief Description of Drawings
[図 1]顔面全体を覆い且つ顔面起伏に沿った形状を有する本願の「シート」の一態様 を示す図である。 FIG. 1 is a view showing an embodiment of the “sheet” of the present application that covers the entire face and has a shape along the face undulation.
[図 2]実施例;!〜 9及び比較例;!〜 6で用いたマスク型を示す図である。なお、図中、 数字は単位: mmを示す。  FIG. 2 is a diagram showing the mask molds used in Examples;! To 9 and Comparative Examples; In the figure, the numbers indicate the unit: mm.
[図 3]実施例 1 (A- 2)の初期弾性率を求める Stress— Strain曲線のグラフである。  FIG. 3 is a stress-strain curve graph for obtaining the initial elastic modulus of Example 1 (A-2).

Claims

請求の範囲 The scope of the claims
[1] i)第 1のポリ口タキサン;及び ii)以下の a)及び/又は b)の物質;を有し、  [1] i) a first poly-oral taxane; and ii) the following substances a) and / or b):
a)ポリ口タキサン以外である第 1のポリマー;  a) a first polymer that is other than a polymouth taxane;
b)第 2のポリ口タキサン、  b) a second polymouth taxane,
且つ該 i)第 1のポリ口タキサンと該 ii)物質とが化学的及び/又は物理的に結合して なるパック用シートであって、  And i) the first poly (oral taxane) and the ii) substance chemically and / or physically bonded,
前記 i)第 1のポリ口タキサンは、第 1の環状分子、該第 1の環状分子を串刺し状に包 接する第 1の直鎖状分子、及び該第 1の直鎖状分子から前記第 1の環状分子が脱離 しないように第 1の直鎖状分子の両端に配置される第 1の封鎖基を有し、  The i) first poly (taxane) taxane includes a first cyclic molecule, a first linear molecule that includes the first cyclic molecule in a skewered manner, and the first linear molecule from the first linear molecule. Having a first blocking group disposed at both ends of the first linear molecule so that the cyclic molecule of
前記 b)第 2のポリ口タキサンは、第 1の環状分子と同じであっても異なってもよい第 2 の環状分子、該第 2の環状分子を串刺し状に包接する第 2の直鎖状分子であって前 記第 1の直鎖状分子と同じであっても異なってもよい第 2の直鎖状分子、及び該第 2 の直鎖状分子から前記第 2の環状分子が脱離しないように第 2の直鎖状分子の両端 に配置される第 2の封鎖基であって第 1の封鎖基と同じであっても異なってもよい第 2 の封鎖基を有し、  The b) second poly-taxane is a second cyclic molecule that may be the same as or different from the first cyclic molecule, and a second linear chain that includes the second cyclic molecule in a skewered manner. A second linear molecule which may be the same as or different from the first linear molecule, and the second cyclic molecule is detached from the second linear molecule. A second blocking group disposed at both ends of the second linear molecule so that the second blocking group may be the same as or different from the first blocking group,
前記パック用シートの最大伸長率が 200%以上であり、破断強度が 30kPa以上で あり且つ初期弾性率が 5〜; !OOkPaである、上記パック用シート。  The pack sheet as described above, wherein the maximum elongation of the pack sheet is 200% or more, the breaking strength is 30 kPa or more, and the initial elastic modulus is 5 to OOkPa.
[2] 前記第 1及び/又は第 2の直鎖状分子が、ポリエチレングリコール、ポリイソプレン、 ポリイソブチレン、ポリブタジエン、ポリプロピレングリコール、ポリテトラヒドロフラン、ポ リジメチルシロキサン、ポリエチレン、及びポリプロピレンからなる群から選ばれる請求 項 1記載のシート。 [2] The first and / or second linear molecule is selected from the group consisting of polyethylene glycol, polyisoprene, polyisobutylene, polybutadiene, polypropylene glycol, polytetrahydrofuran, polydimethylsiloxane, polyethylene, and polypropylene. The sheet according to claim 1.
[3] 前記第 1及び/又は第 2の直鎖状分子は、その分子量が 1万以上である請求項 1 又は 2記載のシート。  [3] The sheet according to claim 1 or 2, wherein the first and / or second linear molecule has a molecular weight of 10,000 or more.
[4] 前記第 1及び/又は第 2の封鎖基が、ジニトロフエニル基類、シクロデキストリン類、 ァダマンタン基類、トリチル基類、フルォレセイン類、ピレン類、置換ベンゼン類、置 換されて!/、てもよ!/、多核芳香族類、及びステロイド類からなる群から選ばれる請求項 ;!〜 3のいずれか 1項記載のシート。  [4] The first and / or second blocking group is replaced with dinitrophenyl groups, cyclodextrins, adamantane groups, trityl groups, fluoresceins, pyrenes, substituted benzenes, The sheet according to any one of claims 1 to 3, which is selected from the group consisting of Moyo! /, Polynuclear aromatics, and steroids.
[5] 前記第 1及び/第 2の環状分子が置換されていてもよいシクロデキストリン分子であ る請求項:!〜 4のいずれか 1項記載のシート。 [5] A cyclodextrin molecule in which the first and / or second cyclic molecule may be substituted. The sheet according to any one of claims 4 to 4.
[6] 前記第 1及び/又は第 2の環状分子が置換されてレ、てもよ!/、シクロデキストリン分 子であり、該シクロデキストリン分子が α —シクロデキストリン、 0—シクロデキストリン 及び γ—シクロデキストリン、並びにその誘導体からなる群から選ばれる請求項 1〜5 のいずれか 1項記載のシート。 [6] The first and / or second cyclic molecule may be substituted and may be a cyclodextrin molecule, and the cyclodextrin molecule may be α-cyclodextrin, 0-cyclodextrin and γ- The sheet according to any one of claims 1 to 5, which is selected from the group consisting of cyclodextrin and derivatives thereof.
[7] 前記第 1及び/又は第 2の環状分子が置換されていてもよい α—シクロデキストリ ンであり、前記直鎖状分子がポリエチレングリコールである請求項 1〜6のいずれか 1 項記載のシート。 [7] The first and / or second cyclic molecule is α-cyclodextrin which may be substituted, and the linear molecule is polyethylene glycol. The described sheet.
[8] 前記第 1の環状分子が第 1の直鎖状分子により串刺し状に包接される際に第 1の環 状分子が最大限に包接される量を 1とした場合、前記第 1の環状分子が 0. 00;!〜 0. 6の量で第 1の直鎖状分子に串刺し状に包接される請求項;!〜 7のいずれか 1項記 載のシート。  [8] When the first cyclic molecule is clasped by the first linear molecule in a skewered manner, the maximum amount of inclusion of the first cyclic molecule is 1. The sheet according to any one of claims 1 to 7, wherein 1 cyclic molecule is included in a skewered manner with the first linear molecule in an amount of 0.00;
[9] 前記第 2の環状分子が第 2の直鎖状分子により串刺し状に包接される際に第 2の環 状分子が最大限に包接される量を 1とした場合、前記第 2の環状分子が 0. 00;!〜 0. 6の量で第 2の直鎖状分子に串刺し状に包接される請求項;!〜 8のいずれか 1項記 載のシート。  [9] When the amount by which the second cyclic molecule is maximally included when the second cyclic molecule is included in a skewered manner by the second linear molecule is 1, The sheet according to any one of claims 1 to 8, wherein the two cyclic molecules are included in a skewered manner with the second linear molecule in an amount of 0.00;
PCT/JP2007/068243 2006-09-21 2007-09-20 Sheet for pack WO2008035728A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006256338A JP2009292727A (en) 2006-09-21 2006-09-21 Sheet for pack
JP2006-256338 2006-09-21

Publications (1)

Publication Number Publication Date
WO2008035728A1 true WO2008035728A1 (en) 2008-03-27

Family

ID=39200552

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/068243 WO2008035728A1 (en) 2006-09-21 2007-09-20 Sheet for pack

Country Status (2)

Country Link
JP (1) JP2009292727A (en)
WO (1) WO2008035728A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008155953A1 (en) * 2007-06-15 2008-12-24 The University Of Tokyo POLYROTAXANE HAVING MAIN CHAIN BACKBONE ESSENTIALLY COMPOSED OF -Si-O- AND METHOD FOR PRODUCING THE SAME, AND CROSSLINKED POLYROTAXANE OBTAINED BY CROSSLINKING THE POLYROTAXANE AND METHOD FOR PRODUCING THE SAME
JP2012025923A (en) * 2010-07-28 2012-02-09 Univ Of Tokyo Method for synthesizing polyrotaxane and new polyrotaxane
WO2017188376A1 (en) * 2016-04-27 2017-11-02 国立大学法人大阪大学 Method for producing polyrotaxane
JP2022113157A (en) * 2018-11-08 2022-08-03 株式会社トクヤマ polishing pad

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2931230B1 (en) * 2012-12-11 2018-10-03 Sekisui Specialty Chemicals America, LLC Pvoh copolymers for personal care applications
KR102167526B1 (en) * 2013-06-07 2020-10-19 가부시키가이샤 에이에스엠 Crosslinking composition having a polyrotaxane and a compound having two or more oxirane groups and/or oxetane groups
KR101914967B1 (en) * 2014-11-26 2018-11-05 쿄세라 코포레이션 Resin composition for semiconductor encapsulation and semiconductor device
US11957796B2 (en) 2018-07-11 2024-04-16 The University Of Tokyo Isolated nanosheet and production method thereof
JP7122043B2 (en) * 2019-02-28 2022-08-19 国立大学法人 東京大学 Isolated nanosheet and method for producing the same
WO2022123874A1 (en) * 2020-12-08 2022-06-16 国立研究開発法人物質・材料研究機構 Adhesive sheet and method for producing same
WO2022239753A1 (en) * 2021-05-10 2022-11-17 国立大学法人 東京大学 Nanostructure or microstructure and method for producing same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09216815A (en) * 1996-02-08 1997-08-19 Noevir Co Ltd Skin ointment
JPH09263547A (en) * 1996-03-29 1997-10-07 Nobuhiko Yui Accelerating substance for percutaneous absorption and production of the same
WO2001083566A1 (en) * 2000-04-28 2001-11-08 Center For Advanced Science And Technology Incubation, Ltd. Compound comprising crosslinked polyrotaxane
WO2005095493A1 (en) * 2004-03-31 2005-10-13 The University Of Tokyo Polymeric material having polyrotaxane and process for producing the same
WO2006088200A1 (en) * 2005-02-21 2006-08-24 The University Of Tokyo Material comprising polyrotaxane and polymer and process for producing the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09216815A (en) * 1996-02-08 1997-08-19 Noevir Co Ltd Skin ointment
JPH09263547A (en) * 1996-03-29 1997-10-07 Nobuhiko Yui Accelerating substance for percutaneous absorption and production of the same
WO2001083566A1 (en) * 2000-04-28 2001-11-08 Center For Advanced Science And Technology Incubation, Ltd. Compound comprising crosslinked polyrotaxane
WO2005095493A1 (en) * 2004-03-31 2005-10-13 The University Of Tokyo Polymeric material having polyrotaxane and process for producing the same
WO2006088200A1 (en) * 2005-02-21 2006-08-24 The University Of Tokyo Material comprising polyrotaxane and polymer and process for producing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUDA J. ET AL.: "Slide-ring Gel no Keshohin eno Oyo", KOBUNSHI, vol. 55, no. 10, 1 October 2006 (2006-10-01), pages 817, XP003021846 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008155953A1 (en) * 2007-06-15 2008-12-24 The University Of Tokyo POLYROTAXANE HAVING MAIN CHAIN BACKBONE ESSENTIALLY COMPOSED OF -Si-O- AND METHOD FOR PRODUCING THE SAME, AND CROSSLINKED POLYROTAXANE OBTAINED BY CROSSLINKING THE POLYROTAXANE AND METHOD FOR PRODUCING THE SAME
JP2012025923A (en) * 2010-07-28 2012-02-09 Univ Of Tokyo Method for synthesizing polyrotaxane and new polyrotaxane
WO2017188376A1 (en) * 2016-04-27 2017-11-02 国立大学法人大阪大学 Method for producing polyrotaxane
JPWO2017188376A1 (en) * 2016-04-27 2018-12-20 国立大学法人大阪大学 Method for producing polyrotaxane
JP2022113157A (en) * 2018-11-08 2022-08-03 株式会社トクヤマ polishing pad

Also Published As

Publication number Publication date
JP2009292727A (en) 2009-12-17

Similar Documents

Publication Publication Date Title
WO2008035728A1 (en) Sheet for pack
KR101180169B1 (en) Polymeric Material Having Polyrotaxane and Process for Producing the Same
Schmidt et al. Complex macromolecular architecture design via cyclodextrin host/guest complexes
TWI438256B (en) An adhesive composition and an adhesive sheet using the same
JP3475252B2 (en) Compound having cross-linked polyrotaxane
CA2598309C (en) Material comprising polyrotaxane and polymer and process for producing the same
Van De Manakker et al. Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications
Schüll et al. Grafting of hyperbranched polymers: From unusual complex polymer topologies to multivalent surface functionalization
WO2007026578A1 (en) Hydrophobic modified polyrotaxane and crosslinked polyrotaxane
EP1749849B1 (en) Materials having crosslinked polyrotaxane and process for producing these
WO2006090819A1 (en) Material having polyrotaxane and polymer, and ionic liquid, and method for production thereof
JP5379470B2 (en) Stimulated responsive polymer crosslinked body and method for producing the same
KR20060136474A (en) Polymeric Material Having Polyrotaxane and Process for Producing the Same
PT1784437E (en) Polymeric materials having reduced tack, methods of making the materials and chewing gum compositions containing such materials
WO2007026594A1 (en) Modified hydrophilic polyrotaxane and cross-linked polyrotaxane
JP2009270120A (en) Solution containing hydrophobic modified polyrotaxane
Wu et al. Room temperature readily self-healing polymer via rationally designing molecular chain and crosslinking bond for flexible electrical sensor
JPWO2009069605A1 (en) Composition comprising a polyrotaxane or a crosslinked polyrotaxane and a multi-component dispersion medium
JP5611087B2 (en) Polymer cross-linking precursor, stimulus-responsive polymer cross-linked product, and production method thereof
Miyashita et al. Phase structure of chitin/poly (glycidyl methacrylate) composites synthesized by a solution coagulation/bulk polymerization method
JP2014152163A (en) Cosmetic
Chen Synthesis and Structure-Property Relationships of Polysaccharide-Based Block Copolymers and Hydrogels
JP2020007648A (en) Fibrous material and fiber reinforced resin composition
JP2007063411A (en) Polyrotaxane with reduced amount of cyclic molecules
KR101103265B1 (en) Cosmetic pack composition containing PPG-Chtosan and Alginate salts.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07807607

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07807607

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP